Asif Rashid, M.B.B.S., Ph.D.

Peer-Reviewed Articles

1. Hatia, RI, Hwang, LY, Li, R, Troisi, CL, Jalal, P, Amos, CI, Gomez, HF, Chun, YS, Rashid, A, Kaseb, A, Scheet, PA, Hassan, MM. Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus. Journal of Hepatocellular Carcinoma 12:93-106, 2025. e-Pub 2025. PMID: 39867264.
2. Yang, RK, Alvarez, HA, Lucas, AS, Roy Chowdhuri, S, Rashid, A, Chen, H, Ballester, L, Sweeney, K, Routbort, MJ, Patel, KP, Luthra, R, Medeiros, LJ, Toruner, GA. Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistry. Cancer Genetics 290-291:44-50, 2025. e-Pub 2025. PMID: 39700818.
3. Zhuravleva E, Lewinska M, O'Rourke CJ, Pea A, Rashid A, Hsing AW, Taranta A, Chang D, Gao Y, Koshiol J, Oliveira RC, Andersen JB. Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma. Gut, 2024. e-Pub 2024. PMID: 39725462.
4. Pehlivanoglu, B, Araya O, JC, Lawrence, S, Roa S, JC, Balci, S, Andersen, JB, Rashid, A, Hsing, AW, Zhu, B, Gao, YT, Koshiol, J, Adsay, V, Miquel, JF, Acevedo, J, Cook, P, Aguayo, CG, Baez, S, Diaz, A, Azócar, L, Molina, H, Miranda, C, Castillo, C, Tello, A, Toledo, F, Wozniak, A, Durán, G, Delgado, CP, Torres-Quevedo, R, Pineda, S, Barra, Tl, Reyes, C, Alegría, C, Aguayo, C, Losada, H, Bellolio, E, Tapia, O, Lopez, J, Medina, K, Barraza, P, Catalán, S, Riquelme, P, Órdenes, L, Garcés, R, Duarte, C, Hildesheim, A. TPPP-BRD9 fusion-related gallbladder carcinomas are frequently associated with intracholecystic neoplasia, neuroendocrine carcinoma, and a distinctive small tubular-type adenocarcinoma commonly accompanied with a syringomatous pattern. Human Pathology 150:67-73, 2024. e-Pub 2024. PMID: 38972607.
5. Hassan, MM, Li, D, Han, Y, Byun, J, Hatia, RI, Long, E, Choi, J, Kelley, RK, Cleary, S, Lok, AS, Bracci, PM, Permuth, JB, Bucur, R, Yuan, JM, Singal, AG, Jalal, P, Ghobrial, RM, Santella, RM, Kono, Y, Shah, DJ, Nguyen, MH, Liu, G, Parikh, ND, Kim, RD, Wu, HC, El-Serag, H, Chang, P, Li, Y, Chun, YS, Lee, SS, Gu, J, Hawk, E, Sun, R, Huff, C, Rashid, A, Amin, H, Beretta, L, Wolff, RA, Antwi, SO, Patt, YZ, Hwang, LY, Klein, AP, Zhang, K, Schmidt, MA, White, DL, Goss, JA, Khaderi, SA, Marrero, JA, Cigarroa, FG, Shah, PK, Kaseb, A, Roberts, LR, Amos, CI. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology 80(1):87-101, 2024. e-Pub 2024. PMID: 38381705.
6. Chamseddine, SM, Lapelusa, M, Carter, K, Nguyen, V, Mohamed, YI, Sakr, Y, Rojas Hernandez, CM, Hatia, RI, Hassan, MM, Goss, JA, Elsayes, KM, Rashid, A, Sun, R, Cao, HT, Amin, H, Kaseb, A. Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab. Journal of Gastrointestinal Oncology 15(3):1324-1330, 2024. e-Pub 2024. PMID: 38989410.
7. Tran Cao, HS, Witt, RG, Elsayes, KM, Baiomy, A, Xiao, L, Palmquist, SM, Lee, SS, Mohamed, YI, Mahvash, A, Tzeng, CD, Chun, YS, Koay, EJ, Rashid, A, Hassan, MM, Yao, JC, Vauthey, JN, Kaseb, A. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist 29(6):e803-e810, 2024. e-Pub 2024. PMID: 38159256.
8. Diks J, Tang Z, Altan M, Anderson S, Chen H, Rashid A, Yang RK, Routbort MJ, Patel KP, Toruner GA, Medeiros LJ, Tang G, Luthra R, Roy-Chowdhuri S. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization. Cancer Cytopathol 132(1):41-49, 2024. e-Pub 2024. PMID: 37747438.
9. Mohamed YI, Lee SS, Demir T, Chamseddine S, Hu ZI, Xiao L, Elsayes K, Morris JS, Wolff RA, Hiatia R, Qayyum A, Rashid A, Duda DG, Yao JC, LaPelusa M, Koay EJ, Mahvash A, Azzam AA, Dumbrava EE, Hassan M, Amin HM, Kaseb AO. Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced hepatocellular carcinoma treated with nivolumab. Cancer Biomark 41(1):83-91, 2024. e-Pub 2024. PMID: 39269823.
10. Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H. Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors. Cancers (Basel) 16(1):6, 2023. e-Pub 2023. PMID: 38201434.
11. Dhingra S, Taggart MW, Foo WC, Rashid A, Heredia MLM, May SB, Van Buren G, Fisher WE, Wang H. Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Ann Clin Lab Sci 53(6):847-860, 2023. e-Pub 2023. PMID: 38182140.
12. Iorgulescu, JB, Shaw, LK, Rashid, A, Rao, P, Mandayam, S, Patel, KP, Schmeler, KM, Yang, RK, Msaouel, P. Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant. Current Oncology 30(10):9019-9027, 2023. e-Pub 2023. PMID: 37887551.
13. Iorgulescu, JB, Shaw, LK, Rashid, A, Rao, P, Mandayam, S, Patel, KP, Schmeler, KM, Yang, RK, Msaouel, P. Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant. Current Oncology 30(10):9019-9027, 2023. e-Pub 2023. PMID: 37887551.
14. Hatia, RI, Eluri, M, Hawk, E, Shalaby, A, Karatas, E, Shalaby, A, Abdelhakeem, AA, Ali, RH, Chang, P, Rashid, A, Jalal, P, Amos, CI, Han, Y, Armaghany, T, Shroff, R, Li, D, Javle, M, Hassan, MM. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiology Biomarkers and Prevention 32(10):1338-1347, 2023. e-Pub 2023. PMID: 37540502.
15. Huey RW, Shah AT, Reddi HV, Dasari P, Topham JT, Hwang H, Dhillon N, Willett A, Smaglo B, Estrella JS, Rashid A, Matamoros A, Overman MJ, Choquette L, Omerza G, Kelly K, Wang X, Loree JM, Rueter J, Varadhachary GR, Raghav K. Feasibility and Value of Genomic-Profiling in Cancer of Unknown Primary: Real-World Evidence from Prospective Profiling Study. J Natl Cancer Inst 115(8):994-997, 2023. e-Pub 2023. PMID: 37202363.
16. Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel) 15(9):2608, 2023. e-Pub 2023. PMID: 37174073.
17. Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol 47(4):421-430, 2023. e-Pub 2023. PMID: 36746143.
18. Mohamed YI, Duda DG, Awiwi MO, Lee SS, Altameemi L, Xiao L, Morris JS, Wolff RA, Elsayes KM, Hatia RI, Qayyum A, Chamseddine SM, Rashid A, Yao JC, Mahvash A, Hassan MM, Amin HM, Kaseb AO. Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients. Oncotarget 13(1):1314-1321, 2022. e-Pub 2022. PMID: 36473155.
19. Yang RK, Chen H, Roy-Chowdhuri S, Rashid A, Alvarez H, Routbort M, Patel KP, Luthra R, Medeiros LJ, Toruner GA. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods. Cancers (Basel) 14(19):4550, 2022. e-Pub 2022. PMID: 36230473.
20. Mehta RS, Saliba RM, Hayase E, Jenq RR, Abraham S, Rashid A, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Popat UR, Qazilbash MH, Ramdial J, Srour S, Champlin RE, Rezvani K, Shpall EJ, Alousi AM. Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?. Transplant Cell Ther 28(8):500.e1-500.e10, 2022. e-Pub 2022. PMID: 35662592.
21. Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 7(3):208-218, 2022. e-Pub 2022. PMID: 35065057.
22. Kaseb AO, Haque A, Vishwamitra D, Hassan MM, Xiao L, George B, Sahu V, Mohamed YI, Carmagnani Pestana R, Lombardo JL, Avritscher R, Yao JC, Wolff RA, Rashid A, Morris JS, Amin HM. Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma. Front Oncol 12:986305, 2022. e-Pub 2022. PMID: 36276070.
23. Haque A, Sahu V, Lombardo JL, Xiao L, George B, Wolff RA, Morris JS, Rashid A, Kopchick JJ, Kaseb AO, Amin HM. Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development. J Hepatocell Carcinoma 9:823-837, 2022. e-Pub 2022. PMID: 35996397.
24. Ramani NS, Patel KP, Routbort MJ, Alvarez H, Broaddus R, Chen H, Rashid A, Lazar A, Lucas FAS, Yao H, Manekia J, Dang H, Barkoh BA, Medeiros LJ, Luthra R, Roy-Chowdhuri S. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing. Arch Pathol Lab Med 145(11):1405-1412, 2021. e-Pub 2021. PMID: 33493304.
25. Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology 21(7):1378-1385, 2021. e-Pub 2021. PMID: 34429247.
26. Moussa I, Day RS, Li R, Kaseb A, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med 10(20):7308-7319, 2021. e-Pub 2021. PMID: 34535983.
27. Chakravarti D, Lee R, Multani AS, Santoni A, Keith Z, Hsu WH, Chang K, Reyes L, Rashid A, Wu CJ, Li J, Zhang J, Shim HS, Chandra K, Deng P, Spring DJ, Nielsen OH, Riis LB, Mayigegowda KK, Blutt SE, Zhang J, Younes M, DuPont A, Thirumurthi S, Vilar E, Estes MK, Colla S, Shroyer NF, DePinho RA. Telomere dysfunction instigates inflammation in inflammatory bowel disease. Proc Natl Acad Sci U S A 118(29), 2021. e-Pub 2021. PMID: 34253611.
28. Zheng J, Daniel CR, Hatia RI, Stuff J, Abdelhakeem AA, Rashid A, Chun YS, Jalal PK, Kaseb AO, Li D, Hassan MM. Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA-Based Study. Hepatology. e-Pub 2021. PMID: 34233041.
29. Moussa I, Day RS, Li R, Du XL, Kaseb AO, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults. Nutrients 13(6), 2021. e-Pub 2021. PMID: 34208122.
30. Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You YN, Taniguchi C, Koay EJ, Bednarski B, Rodriguez-Bigas M, Skibber J, Wolff R, Chang GJ, Minsky BD, Foo WC, Rothschild N, Morris VK, Eng C. CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
31. Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers. Cancer Cytopathol, 2021. e-Pub 2020. PMID: 33119213.
32. Nepal C, Zhu B, O'Rourke CJ, Bhatt DK, Lee D, Song L, Wang D, Van Dyke A, Choo-Wosoba H, Liu Z, Hildesheim A, Goldstein AM, Dean M, LaFuente-Barquero J, Lawrence S, Mutreja K, Olanich ME, Bermejo JL, Group CGR, Ferreccio C, Roa JC, Rashid A, Hsing AW, Gao YT, Chanock SJ, Araya JC, Andersen JB, Koshiol J. Integrative molecular characterization of gallbladder cancer reveals microenvironment-associated subtypes. J Hepatol, 2021. e-Pub 2020. PMID: 33276026.
33. Mohamed YI, Lee S, Xiao L, Hassan MM, Qayyum A, Hiatia R, Pestana RC, Haque A, George B, Rashid A, Duda DG, Elghazaly H, Wolff RA, Morris JS, Yao J, Amin HM, Kaseb AO. Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib. Oncotarget 12(8):756-766, 2021. e-Pub 2021. PMID: 33889299.
34. Qayyum A, Bhosale P, Aslam R, Avritscher R, Ma J, Pagel MD, Sun J, Mohamed Y, Rashid A, Beretta L, Kaseb AO. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. Abdom Radiol (NY) 46(3):1008-1015, 2021. e-Pub 2021. PMID: 32974761.
35. Wei D, Zaid MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology 21(1):200-207, 2021. e-Pub 2021. PMID: 33221151.
36. Cherng HJ, Jain N, Thakral B, Muzzafar T, Miranda RN, Tan D, Rashid A, Kalhor N, Hahn AW, Byers LA, Parseghian CM, Ferrajoli A, Pemmaraju N. Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia. Leuk Res 98:106445, 2020. e-Pub 2020. PMID: 32937250.
37. Morris JS, Hassan MM, Zohner YE, Wang Z, Xiao L, Rashid A, Haque A, Abdel-Wahab R, Mohamed YI, Ballard KL, Wolff RA, George B, Li L, Allen G, Weylandt M, Li D, Wang W, Raghav K, Yao J, Amin HM, Kaseb AO. HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk. Hepatology 73(6):2278-2292. e-Pub 2020. PMID: 32931023.
38. Rashid A, Wang R, Zhang L, Yue J, Yang M, Yen A. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation. Exp Cell Res 394(1):111989, 2020. e-Pub 2020. PMID: 32283065.
39. Chakravarti D, Hu B, Mao X, Rashid A, Li J, Li J, Liao W, Whitley EM, Dey P, Hou P, LaBella KA, Chang A, Wang G, Spring DJ, Deng P, Zhao D, Liang X, Lan Z, Lin Y, Sarkar S, Terranova C, Deribe YL, Blutt SE, Okhuysen P, Zhang J, Vilar E, Nielsen OH, Dupont A, Younes M, Patel KR, Shroyer NF, Rai K, Estes MK, Wang Y, Bertuch AA, DePinho RA. Telomere dysfunction activates YAP1 to drive tissue inflammation. Nat Commun 11(1):4766, 2020. e-Pub 2020. PMID: 32958778.
40. Rashid A, Duan X, Gao F, Yang M, Yen A. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor. Cell Signal 71:109555, 2020. e-Pub 2020. PMID: 32032659.
41. Rashid A, Duan X, Gao F, Yang M, Yen A. Roscovitine enhances all-trans retinoic acid (ATRA)-induced nuclear enrichment of an ensemble of activated signaling molecules and augments ATRA-induced myeloid cell differentiation. Oncotarget 11(12):1017-1036, 2020. e-Pub 2020. PMID: 32256976.
42. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2020. PMID: 31383963.
43. Chen J, Mitra A, Li S, Song S, Nguyen BN, Chen JS, Shin JH, Gough NR, Lin P, Obias V, He AR, Yao Z, Malta TM, Noushmehr H, Latham PS, Su X, Rashid A, Mishra B, Wu RC, Mishra L. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling. Cancer Res 80(9):1819-1832. e-Pub 2020. PMID: 32127355.
44. Lee M, Gao Y, Huang Y, McGee EE, Lam T, Wang B, Shen M, Rashid A, Pfeiffer RM, Hsing AW, Koshiol J. A Metallomic Approach to Assess Associations of Serum Metal Levels With Gallstones and Gallbladder Cancer. Hepatology 71(3):917-928, 2020. e-Pub 2020. PMID: 31318976.
45. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of =?20?mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 8(2):E115-E121, 2020. e-Pub 2020. PMID: 32010742.
46. Abdel-Wahab R, Hassan MM, George B, Pestana RC, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey J, Aloia TA, Tzeng C, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology 98(12):836-846, 2020. e-Pub 2020. PMID: 33027788.
47. Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO. Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study. J Hepatocell Carcinoma 7:143-153, 2020. e-Pub 2020. PMID: 32984091.
48. Sonoda K, Samdani RT, Ikoma N, Kaya DM, Blum-Murphy M, Ajani JA, Badgwell BD, Katz MH, Rashid A, Estrella JS. Gastric cancer in the remnant stomach after pancreaticoduodenectomy: A case series. J Surg Oncol 120(7):1137-1141, 2019. e-Pub 2019. PMID: 31498442.
49. Wang M, Estrella JS, Katz MH, Kim M, Rashid A, Lee JE, Maitra A, Wistuba II, Wolff RA, Varadhachary GR, Wang H. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. Pancreas 48(10):1367-1372, 2019. e-Pub 2019. PMID: 31688603.
50. Qayyum A, Hwang KP, Stafford J, Verma A, Maru DM, Sandesh S, Sun J, Pestana RC, Avritscher R, Hassan MM, Amin H, Rashid A, Wistuba II, Ehman RL, Ma J, Kaseb AO. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC. J Immunother Cancer 7(1):329, 2019. e-Pub 2019. PMID: 31779702.
51. Kaseb AO, Sánchez NS, Sen S, Kelley RK, Tan B, Bocobo AG, Lim KH, Abdel-Wahab R, Uemura M, Pestana RC, Qiao W, Xiao L, Morris J, Amin HM, Hassan MM, Rashid A, Banks KC, Lanman RB, Talasaz A, Mills-Shaw KR, George B, Haque A, S Raghav KP, Wolff RA, Yao JC, Meric-Bernstam F, Ikeda S, Kurzrock R. Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA. Clin Cancer Res 25(20):6107-6118, 2019. e-Pub 2019. PMID: 31363003.
52. Samdani RT, Wasylishen AR, Halperin DM, Dasari A, Yao JC, Rashid A, Estrella JS. Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors: Comparison Between Primary and Metastatic Tumors. Pancreas 48(4):510-513, 2019. e-Pub 2019. PMID: 30946241.
53. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20mm colon polyps. Endosc Int Open 7(3):E361-E366, 2019. e-Pub 2019. PMID: 30834295.
54. Pestana RC, Hassan MM, Abdel-Wahab R, Abugabal YI, Girard LM, Li D, Chang P, Raghav K, Morris J, Wolff RA, Rashid A, Amin HM, Kaseb A. Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. Oncotarget 9(102):37721–37732, 2018. e-Pub 2018. PMID: 30701027.
55. Muñoz NM, Minhaj AA, Maldonado KL, Kingsley CV, Cortes AC, Taghavi H, Polak U, Mitchell JM, Ensor JE, Bankson JA, Rashid A, Avritscher R. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma. Magn Reson Imaging S0730-725X:30201-30207. e-Pub 2018. PMID: 30465870.
56. Chen H, Luthra R, Patel KP, Routbort M, Rashid A, Roy-Chowdhuri S, Lazar A, Broaddus R, Manekia J, Singh RR, Yemelyanova A. Challenges in next generation sequencing analysis of somatic mutations in transplant patients. Cancer Genet:226-227-17-22, 2018. e-Pub 2018. PMID: 30005850.
57. CHAVEZ AAL, IYER P, CAZACU IM, CABANILLAS ME, RASHID A, BHUTANI MS. Anaplastic Thyroid Carcinoma with Gastric Metastasis. Curr Health Sci J 44(3):294-298, 2018. e-Pub 2018. PMID: 30647951.
58. Koshiol J, Gao YT, Corbel A, Kemp TJ, Shen MC, Hildesheim A, Hsing AW, Rashid A, Wang B, Pfeiffer RM, Pinto LA. Circulating inflammatory proteins and gallbladder cancer: potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. Cancer Epidemiol 54:25-30, 2018. e-Pub 2018. PMID: 29554539.
59. Hui L, Rashid A, Foo WC, Katz MH, Chatterjee D, Wang H, Fleming JB, Tamm EP, Wang H. Significance of T1a and T1b carcinoma arising in mucinous cystic neoplasm of pancreas. Am J Surg Pathol 42(5):578-586, 2018. e-Pub 2018. PMID: 29462092.
60. Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Roa JC, Wang B, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA, Koshiol J. Circulating levels of inflammatory proteins and survival in patients with gallbladder cancer. Sci Rep 10(1):5671, 2018. e-Pub 2018. PMID: 29618736.
61. Chen J, Zaidi S, Rao S, Chen JS, Phan L, Farci P, Su X, Shetty K, White J, Zamboni F, Wu X, Rashid A, Pattabiraman N, Mazumder R, Horvath A, Wu RC, Li S, Xiao C, Deng CX, Wheeler DA, Mishra B, Akbani R, Mishra L. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway. Gastroenterology 154(1):195-210, 2018. e-Pub 2018. PMID: 28918914.
62. Uberoi AS, Rashid A, Bhutani MS. Leukemic infiltration of colon in a case of diarrhea post hematopoietic cell transplantation. Clinical Gastroenterology Hepatology 16(6):31041-8, 2018. e-Pub 2018. PMID: 28864271.
63. Liu Z, Kemp TJ, Y-T G, Corbel A, McGee EE, Wang B, Shen MC, Rashid A, Hsing AW, Hildesheim A, Pfeiffer RM, Pinto LA, Koshiol J. The association of circulating inflammatory proteins and gallstone disease. Journal of Gastroenterology and Hepatology 33(11):1920-1924, 2018. e-Pub 2018. PMID: 29671891.
64. Chen J, Zaidi S, Rao S, Chen JS, Phan L, Farci P, Su X, Shetty K, White J, Zamboni J, Wu X, Rashid A, Pattabiraman N, Mazumber R, Horvath A, Wu RC, Li S, Xiao C, Deng CX, Wheeler DA, Mishra B, Akbani R, Mishra L. Analysis of genomes and transcriptomes of hepatocellular carcinomas identifies mutations and gene expression changes in the transforming growth factor beta pathway. Gastroenterology 154(1):195-210, 2018. e-Pub 2018. PMID: 28918914.
65. Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Am J Surg Pathol 41(8):1097-1104, 2017. e-Pub 2017. PMID: 28614206.
66. Koshiol J, Gao Y, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke AL, Ferreccio C, Malasky M, Shen M, Zhu B, Andersen JB, Hildesheim A, Hsing AW, Groopman J. Association of aflatoxin and gallbladder cancer. Gastroenterology 153(2):488-494.e1, 2017. e-Pub 2017. PMID: 28428144.
67. Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford):S1365-182X. e-Pub 2017. PMID: 28528267.
68. Rogers JE, Bolonesi RM, Rashid A, Elsayes KM, Elbanan MG, Law L, Kaseb A, Shroff RT. Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol 8(2):347-351, 2017. e-Pub 2017. PMID: 28480073.
69. Roland CL, Starker LF, Kang Y, Chatterjee D, Estrella J, Rashid A, Katz MH, Aloia TA, Lee JE, Dasari A, Yao JC, Fleming JB. Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery 161(3):753-759, 2017. e-Pub 2017. PMID: 27816207.
70. Chen J, Shukla V, Farci P, Andricovich J, Jogunoori W, Kwong LN, Katz LH, Shetty K, Rashid A, Su X, White J, Li L, Wang AY, Blechacz B, Marta Davila GSR, Nguyen B, Stroehlein JR, Chen J, Kim SS, Levin H, Machida K, Tsukamoto H, Michaely P, Tzatsos A, Mishra B, Amdur R, Mishra L. Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instability. Hepatology 65(2):678-693, 2017. e-Pub 2017. PMID: 28114741.
71. Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
72. Nejati R, Goldstein JB, Halperin DM, Wang H, Hejazi N, Rashid A, Katz MH, Lee JE, Fleming JB, Rodriquez-Canales J, Blando J, Wistuba II, Maitra A, Wolff RA, Varadhachary GR, Wang H. Prognostic significance of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemotherapy. Pancreas 46:1180-1187, 2017. e-Pub 2017.
73. Morris VK, Rao X, Pickering CR, Foo WC, Rashid A, Eterovic AK, Tim TB, Chen K, Shaw K, Eng C. Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal. Molecular Cancer Research 15(11):1542-1550, 2017. e-Pub 2017. PMID: 28784613.
74. Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol:S1542-3565, 2017. e-Pub 2017. PMID: 28579181.
75. Nelson SM, Gao YT, Nogueira LM, Shen MC, Wang B, Rashid A, Hsing AW, Koshiol J. Diet and biliary tract cancer risk in Shanghai, China. PLoS One 12(3):e0173935, 2017. e-Pub 2017. PMID: 28288186.
76. Liu Q, Stewart J, Wang H, Rashid A, Zhao J, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang H. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLoS One 12(2):e0171985, 2017. e-Pub 2017. PMID: 28187218.
77. Zuo X, Xu W, Xu M, Tian R, Moussalli MJ, Mao F, Zheng X, Wang J, Morris JS, Gagea M, Eng C, Kopetz S, Maru DM, Rashid A, Broaddus R, Wei D, M-C H, Sood AK, Shureqi I. Metastasis regulated by PPARD expression in cancer cells. JCI Insight 2(1), 2017. e-Pub 2017. PMID: 28097239.
78. Im JS, Abraham SC, Saliba RM, Rondon G, Ross WA, Rashid A, Shpall EJ, Popat U, Qazilbash MH, Hosing C, Oran B, Shah N, Tewari P, Nieto Y, Kebriaei P, Champlin RE, Alousi AM. Histologic grade 1 is associated with increased non-relapsed mortality in lower gastrointestinal graft-versus-host disease. American Journal of Surgical Pathology 41(11):1483-1490, 2017. e-Pub 2017. PMID: 28834808.
79. Lee SM, Katz MH, Liu L, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival. Am J Surg Pathol 40(12):1653-1660, 2016. e-Pub 2016. PMID: 27631521.
80. Chen J, Shukla V, Farci P, Andricovich J, Jogunoori W, Kwong LN, Katz LH, Shetty K, Rashid A, Su X, White J, Li L, Wang AY, Blechacz B, Raju GS, Davila M, Nguyen BN, Stroehlein JR, Chen J, Kim SS, Levin H, Machida K, Tsukamoto H, Michaely P, Tzatsos A, Mishra L. Loss of the TGF-β Effector β2SP Promotes Genomic Instability. Hepatology 65:678-693. e-Pub 2016. PMID: 27831662.
81. Van Dyke AL, Kemp TJ, Corbel AF, Zhu B, Gao YT, Wang BS, Rashid A, Shen MC, Hildesheim A, Hsing AW, Pinto LA, Koshiol J. Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation. Ann Epidemiol 26(10):704-709, 2016. e-Pub 2016. PMID: 27793274.
82. Kaseb AO, Hassan M, Lacin S, Abdel-Wahab R, Amin HM, Shalaby A, Wolff RA, Yao J, Rashid A, Vennapusa B, Feng J, Ohtomo T. Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma. Oncotarget 7(43):69916-69926, 2016. e-Pub 2016. PMID: 27655712.
83. Raju GS, Lum PJ, Ross WA, Thirumurthi S, Miller E, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila ML, Stroehlein JR. Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc 84(2):315-25, 2016. e-Pub 2016. PMID: 26859866.
84. Koshiol J, Castro F, Kemp TJ, Gao YT, Roa JC, Wang B, Nogueira L, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA. Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies. Cytokine 83:217-25, 2016. e-Pub 2016. PMID: 27173614.
85. Chen J, Katz LH, Muñoz NM, Gu S, Shin JH, Jogunoori WS, Lee MH, Belkin MD, Kim SB, White JC, Andricovich J, Tzatsos A, Li S, Kim SS, Shetty K, Mishra B, Rashid A, Lee JS, Mishra L. Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation. Sci Rep 6:30217, 2016. e-Pub 2016. PMID: 27456065.
86. Zuo M, Rashid A, Wang Y, Jain A, Li D, Behari A, Kapoor VK, Koay EJ, Chang P, Vauthey JN, Li Y, Espinoza JA, Roa JC, Javle M. RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer. Oncotarget 7(23):35302-12, 2016. e-Pub 2016. PMID: 27167107.
87. Conte B, George B, Overman M, Estrella J, Jiang ZQ, Mehrvarz Sarshekeh A, Ferrarotto R, Hoff PM, Rashid A, Yao JC, Kopetz S, Dasari A. High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients. Clin Colorectal Cancer 15(2):e1-7, 2016. e-Pub 2016. PMID: 26810202.
88. Ertem F, Dashwood WM, Rajendran P, Raju G, Rashid A, Dashwood R. Development of a murine colonoscopic polypectomy model (with videos). Gastrointest Endosc 83:1272-1276, 2016. e-Pub 2016. PMID: 26658879.
89. Huang FY, Chan AO, Rashid A, Wong DK, Seto WK, Cho CH, Lai CL, Yuen MF. Interleukin-1β increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse model. Oncol Lett 11(4):2919-2924, 2016. e-Pub 2016. PMID: 27073577.
90. Chen J, Yao ZX, Chen JS, Gi YJ, Muñoz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila M, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra L. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. J Clin Invest 126(2):527-42, 2016. e-Pub 2016. PMID: 26784546.
91. Fischer LK, Katz MH, Lee SM, Liu L, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Roland CL, Fleming JB, Estrella J, Rashid A, Wang H. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology 68(2):210-20, 2016. e-Pub 2016. PMID: 25945396.
92. Mitchell J, Tinkey PT, Avritscher R, Van Pelt C, Eskandari G, Konnath George S, Xiao L, Cressman E, Morris JS, Rashid A, Kaseb AO, Amin HM, Uthamanthil R. Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs. Oncology 91(2):90-100, 2016. e-Pub 2016. PMID: 27305144.
93. Voong KR, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC, Wolff RA, Skibber JM, Feig BW, Chang GJ, Das P. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Am J Clin Oncol 40(6):555-560, 2016. e-Pub 2016. PMID: 26237193.
94. Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, Li S, Lin SH, Javle M, McMurray JS, Rahlfs TF, Mishra B, White J, Rashid A, Beauchemin N, Weston BR, Shafi MA, Stroehlein JR, Davila M, Akbani R, Weinstein JN, Wu X, Mishra L. Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas. PLoS One 11(4):e0153933, 2016. e-Pub 2016. PMID: 27100181.
95. Estrella JS, Tetzlaff MT, Bassett RL, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing. Mol Cancer Ther 14(12):2887-95, 2015. e-Pub 2015. PMID: 26438153.
96. Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang G, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist 20(11):1247-52, 2015. e-Pub 2015. PMID: 26382740.
97. Xia M, Overman MJ, Rashid A, Chatterjee D, Wang H, Katz MH, Fleming JB, Lee JE, Varadhachary GR, Wolff RA, Wang H. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma. Hum Pathol 46(9):1315-22, 2015. e-Pub 2015. PMID: 26165226.
98. Abdel-Wahab R, Shehata S, Hassan MM, Xiao L, Lee JS, Cheung S, Essa HH, Hassabo HM, Shalaby AS, Mosad E, Raghav K, Rashid A, Wolff RA, Morris JS, Amin HM, Kaseb AO. Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma. Oncotarget 6(25):21193-207, 2015. e-Pub 2015. PMID: 26098859.
99. Dasari A, Phan A, Gupta S, Rashid A, Yeung SC, Hess K, Chen H, Tarco E, Chen H, Wei C, Anh-Do K, Halperin D, Meric-Bernstam F, Yao J. Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors. Endocr Relat Cancer 22(3):431-41, 2015. e-Pub 2015. PMID: 25900182.
100. Taggart MW, Abraham SC, Overman MJ, Mansfield PF, Rashid A. Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med 139(6):782-90, 2015. e-Pub 2015. PMID: 26030247.
101. Zhu H, Berkova Z, Mathur R, Sehgal L, Khashab T, Tao RH, Ao X, Feng L, Sabichi AL, Blechacz B, Rashid A, Samaniego F. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer. Mol Cancer Res 13(5):809-18, 2015. e-Pub 2015. PMID: 25678597.
102. Zhang J, Jiao J, Cermelli S, Muir K, Jung KH, Zou R, Rashid A, Gagea M, Zabludoff S, Kalluri R, Beretta L. miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. Cancer Res 75(9):1859-67, 2015. e-Pub 2015. PMID: 25769721.
103. Ross WA, Thirumurthi S, Lynch PM, Rashid A, Pande M, Shafi MA, Lee JH, Raju GS. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards?. Gastrointest Endosc 81(3):567-74, 2015. e-Pub 2015. PMID: 25583558.
104. Zuo M, Rashid A, Churi C, Vauthey JN, Chang P, Li Y, Hung MC, Li D, Javle M. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer. Br J Cancer 112(6):1042-51, 2015. e-Pub 2015. PMID: 25742482.
105. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
106. Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 91(1):116-23, 2015. e-Pub 2015. PMID: 25446610.
107. Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang H. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol 39(10):1395-1403, 2015. e-Pub 2015. PMID: 26200098.
108. Raju GS, Lum PJ, Slack RS, Thirumurthi S, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc 82(3):512-9, 2015. e-Pub 2015. PMID: 25910665.
109. Estrella JS, Ma LT, Milton DR, Yao JC, Wang H, Rashid A, Broaddus RR. Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy. Pancreas 43(7):996-1002, 2014. e-Pub 2014. PMID: 25058880.
110. Wang H, Estrella JS, Chatterjee D, Katz MH, Rashid A, Wang H, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB. Hepatobiliary/Pancreas Pathology: SY11-3 PANCREATIC DUCTAL ADENOCARCINOMA: NEOADJUVANT THERAPIES AND PATHOLOGY. Pathology 46 Suppl 2:S25, 2014. e-Pub 2014. PMID: 25188109.
111. Estrella JS, Taggart MW, Rashid A, Abraham SC. Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway. Hum Pathol 45(10):2051-8, 2014. e-Pub 2014. PMID: 25149552.
112. Patel VR, Hofstetter WL, Correa AM, Agarwal A, Rashid A, Bhutani MS, Lin SH, Ajani JA, Swisher SG, Maru DM. Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation. Ann Thorac Surg 98(3):1064-71, 2014. e-Pub 2014. PMID: 25038008.
113. Muñoz NM, Katz LH, Shina JH, Gi YJ, Menon VK, Gagea M, Rashid A, Chen J, Mishra L. Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruption. Genes Cancer 5(9-10):348-52, 2014. e-Pub 2014. PMID: 25352951.
114. Estrella JS, Broaddus RR, Mathews A, Milton DR, Yao JC, Wang H, Rashid A. Progesterone receptor and PTEN expression predict survival in patients with low and intermediate grade pancreatic neuroendocrine tumors. Arch Pathol Lab Med 138(8):1027-36, 2014. e-Pub 2014. PMID: 25076292.
115. Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia T, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst 106(5), 2014. e-Pub 2014. PMID: 24815863.
116. Guo R, Overman M, Chatterjee D, Rashid A, Shroff S, Wang H, Katz MH, Fleming JB, Varadhachary GR, Abbruzzese JL, Wang H. Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma. Hum Pathol 45(5):1015-23, 2014. e-Pub 2014. PMID: 24746206.
117. Shroff S, Rashid A, Wang H, Katz MH, Abbruzzese JL, Fleming JB, Wang H. Sox9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum Pathol 45(3):456-63, 2014. e-Pub 2014. PMID: 24418153.
118. Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol 38(2):147-57, 2014. e-Pub 2014. PMID: 24418850.
119. Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes K. Imaging features of fibrolamellar hepatocellular carcinoma. American Journal of Roentgenology 202:544-552, 2014. e-Pub 2014. PMID: 24555590.
120. Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff R, Aloia TA, J-N V, Curley S, Mills G, Roa I. Molecular characterization of gallbladder cancer using somatic mutation profiling. Human Pathology 45:701-708, 2014. e-Pub 2014. PMID: 24508317.
121. Ramineni M, Taggart MW, Rashid A, Abraham SC. Benign glandular downgrowth in gastric neuroendocrine neoplasms: a potential mimic of composite tumor. Histopathology 65:897-907, 2014. e-Pub 2014. PMID: 25041266.
122. Churi CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J, Zuo M, Zinner R, Hong D, Meric-Bernstam F, Janku F, Crane CH, Mishra L, Vauthey JN, Wolff RA, Mills G, Javle M. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS One 9(12):e115383, 2014. e-Pub 2014. PMID: 25536104.
123. Chatterjee D, Katz MH, Rashid A, Estrella JS, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. Histopathology 63(6):841-51, 2013. e-Pub 2013. PMID: 24111684.
124. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-41, 2013. e-Pub 2013. PMID: 24089344.
125. Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol 44(12):2792-8, 2013. e-Pub 2013. PMID: 24139211.
126. Shroff S, Overman MJ, Rashid A, Shroff RT, Wang H, Chatterjee D, Katz MH, Lee JE, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. Arch Pathol Lab Med 137(11):1619-26, 2013. e-Pub 2013. PMID: 24168499.
127. Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog 52 Suppl 1:E139-47, 2013. e-Pub 2013. PMID: 23776098.
128. Estrella JS, Othman ML, Taggart MW, Hamilton SR, Curley SA, Rashid A, Abraham SC. Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome. Am J Surg Pathol 37(10):1571-9, 2013. e-Pub 2013. PMID: 23797727.
129. Chen N, Balasenthil S, Reuther J, Frayna A, Wang Y, Chandler DS, Abruzzo LV, Rashid A, Rodriguez J, Lozano G, Cao Y, Lokken E, Chen J, Frazier ML, Sahin AA, Wistuba II, Sen S, Lott ST, Killary AM. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. Cancer Discov 3(10):1172-89, 2013. e-Pub 2013. PMID: 23838884.
130. Taggart MW, Overman MJ, Royal RE, Fournier KF, Galbinea JM, Rashid A, Mansfield JF, Abraham SC. High level microsatellite instability in appendiceal adenocarcinomas. American Journal of Surgical Pathology 37(8):1192-200. e-Pub 2013. PMID: 23648460.
131. Huang FY, Chan AO, Lo RC, Rashid A, Wong DK, Cho CH, Lai CL, Yuen MF. Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-/-)) mice. Eur J Cancer 49(12):2760-70, 2013. e-Pub 2013. PMID: 23664095.
132. Taggart MW, Galbincea J, Mansfield PF, Fournier KF, Royal RE, Overman MJ, Rashid A, Abraham SC. High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol 37(8):1192-200, 2013. e-Pub 2013. PMID: 23648460.
133. Foo WC, Rashid A, Wang H, Katz MH, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. Hum Pathol 44(6):1024-30, 2013. e-Pub 2013. PMID: 23260327.
134. Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine tumors of the colon and rectum: Prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol 20(4):1170-8, 2013. e-Pub 2013. PMID: 23212760.
135. Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: Importance of histologic subtype. J Surg Oncol 107(2):136-43, 2013. e-Pub 2013. PMID: 22767417.
136. Li L, Othman M, Rashid A, Wang H, Li Z, Katz MH, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells. Histopathology 62(3):465-71, 2013. e-Pub 2013. PMID: 23134473.
137. Taggart MW, Rashid A, Ross WA, Abraham SC. Oesophageal hyperkeratosis: clinicopathological associations. Histopathology 63:463-473, 2013. e-Pub 2013. PMID: 23879628.
138. Chen WC, Weston B, Krishna SG, Gomez G, Rashid A, Katz HG, Lee JE. Prolonged Endoscopic Loop Ligation for Removal of Gastrointestinal Tumors. Endoscopy 45 Suppl 2:E69-70, 2013. e-Pub 2013. PMID: 23526523.
139. Castro FA, Koshiol J, Hsing AW, Gao YT, Rashid A, Chu LW, Shen MC, Wang BS, Han TQ, Zhang BH, Niwa S, Yu K, Zhang H, Chanock S, Andreotti G. Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China. BMC Cancer 12(1):468, 2012. e-Pub 2012. PMID: 23057767.
140. Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118(15):3801-11, 2012. e-Pub 2012. PMID: 22180096.
141. Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Histologic grading the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: A predictor for patient outcome. Cancer 118(12):3182-90, 2012. e-Pub 2012. PMID: 22028089.
142. Deqin M, Chen Z, Nero C, Patel KP, Daoud EM, Cheng H, Djordjevic B, Broaddus RR, Medeiros LJ, Rashid A, Luthra R. Somatic deletions of the polyA tract in the 3' untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas. Arch Pathol Lab Med 136(5):510-516, 2012. e-Pub 2012. PMID: 22540299.
143. Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Lee JE, Pisters PW, Gomex HF, Abbruzzese JL, Fleming JB, Wang H. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol 36(4):552-559, 2012. e-Pub 2012. PMID: 22301496.
144. Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 82(4):1367-75, 2012. e-Pub 2012. PMID: 21775070.
145. Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 36(3):409-417, 2012. e-Pub 2012. PMID: 22301497.
146. Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rashid A, Crosby K, Dong M, Phan AT, Wolff RA, Gupta S, Mills GB, Yao J. PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res 18(6):1777-89, 2012. e-Pub 2012. PMID: 22422409.
147. Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118(1):268-277, 2012. e-Pub 2012. PMID: 21735446.
148. Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, Balachandran A, Varadhachary GR, Pisters PW, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol 16(1):29-37, 2012. e-Pub 2012. PMID: 22050964.
149. Huang FY, Chan AO, Rashid A, Wong DK, Cho CH, Yuen MF. Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells. Cancer 118:4969-4980, 2012. e-Pub 2012. PMID: 22415887.
150. Bartley AN, Yao H, Barkoh BA, Ivan C, Mishra BM, Rashid A, Calin GA, Luthra R, Hamilton SR. Complex patterns of altered microRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res 17(23):7283-7293, 2011. e-Pub 2011. PMID: 21948089.
151. Gaur P, Sceusi EL, Samuel S, Xia L, Fan F, Zhou Y, Lu J, Tozzi F, Lopez-Berestein G, Vivas-Mejia P, Rashid A, Fleming JB, Abdalla EK, Curley SA, Vauthey JN, Sood AK, Yao JC, Ellis LM. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology 141(5):1728-37, 2011. e-Pub 2011. PMID: 21806944.
152. Shebl FM, Andreotti G, Meyer TE, Gao YT, Rashid A, Yu K, Shen MC, Wang BS, Han TQ, Zhang BH, Stanczyk FZ, Hsing AW. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer 105(9):1424-9, 2011. e-Pub 2011. PMID: 21915122.
153. Bartley AN, Rashid A, Fournier KF, Abraham SC. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors. Hum Pathol 42(10):1420-9, 2011. e-Pub 2011. PMID: 21419473.
154. Andreotti G, Liu E, Gao YT, Safaeian M, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Hsing AW. Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation. Cancer Causes Control 22(9):1289-96, 2011. e-Pub 2011. PMID: 21744094.
155. Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169-77, 2011. e-Pub 2011. PMID: 21334720.
156. Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiotherapy for Patients with Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2011. PMID: 21775070.
157. Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol 35(7):1045-53, 2011. e-Pub 2011. PMID: 21602659.
158. Kaseb AO, Hassan MM, Lin E, Xiao L, Kumar V, Pathak P, Lozano R, Rashid A, Abbruzzese JL, Morris JS. V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer 117:2478-2488, 2011. e-Pub 2011. PMID: 21157958.
159. Safaeian M, Gao YT, Sakoda LC, Quraishi SM, Rashid A, Wang BS, Chen J, Pruckler J, Mintz E, Hsing AW. Chronic typhoid infection and the risk of biliary tract cancer and stones in Shanghai, China. Infect Agent Cancer 6:6, 2011. e-Pub 2011. PMID: 21535882.
160. Estrella JS, Wu TT, Rashid A, Abraham SC. Mucosal colonization by metastatic carcinoma in the gastrointestinal tract: a potential mimic of primary neoplasia. Am J Surg Pathol 35(4):563-72, 2011. e-Pub 2011. PMID: 21412071.
161. Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H. Overexpression of receptor tyrosine Kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117(4):734-43, 2011. e-Pub 2011. PMID: 20922806.
162. Xu HL, Cheng JR, Andreotti G, Gao YT, Rashid A, Wang BS, Shen MC, Chu LW, Yu K, Hsing AW. Cholesterol Metabolism Gene Polymorphisms and the Risk of Biliary Tract Cancers and Stones: A Population-Based Case-Control Study in Shanghai, China. Carcinogenesis 32(1):58-62, 2011. e-Pub 2011. PMID: 21062971.
163. Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. Oncology 80(5-6):373-81, 2011. e-Pub 2011. PMID: 21822028.
164. Goodarzi M, Rashid A, Maru D. Invasive ductal adenocarcinoma arising from pancreatic heterotopia in rectum: case report and review of literature. Hum Pathol 41(12):1809-13, 2010. e-Pub 2010. PMID: 20869744.
165. Abadeer RA, Fleming JB, Deavers MT, Rashid A, Evans DB, Wang H. Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. Ann Diagn Pathol 14(6):457-60, 2010. e-Pub 2010. PMID: 21074697.
166. Yao ZX, Jogunoori W, Choufani S, Rashid A, Blake T, Yao W, Kreishman P, Amin R, Sidawy AA, Evans SR, Finegold M, Reddy EP, Mishra B, Weksberg R, Kumar R, Mishra L. Epigenetic silencing of {beta}-spectrin, a TGF-{beta} signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome. J Biol Chem 285(46):36112-20, 2010. e-Pub 2010. PMID: 20739274.
167. Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 16(14):3734-42, 2010. e-Pub 2010. PMID: 20628027.
168. Fang X, Gupta N, Shen SS, Tamboli P, Charnsangavej C, Rashid A, Wang H. Intra-luminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med 134(7):1003-1009, 2010. e-Pub 2010. PMID: 20586628.
169. Shebl FM, Andreotti G, Rashid A, Gao YT, Yu K, Shen MC, Wang BS, Li Q, Han TQ, Zhang BH, Fraumeni JF, Hsing AW. Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer 103(1):115-9, 2010. e-Pub 2010. PMID: 20517308.
170. Park SK, Andreotti G, Rashid A, Chen J, Rosenberg PS, Yu K, Olsen J, Gao YT, Deng J, Sakoda LC, Zhang M, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Chanock SJ, Hsing AW. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis 31(5):842-6, 2010. e-Pub 2010. PMID: 20172949.
171. Ajani JA, Wang X, Izzo JG, Crane CH, Eng C, Skibber JM, Das P, Rashid A. Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation. Dig Dis Sci 55(4):1098-105, 2010. e-Pub 2010. PMID: 19399614.
172. Thenappan A, Li Y, Kitisin K, Rashid A, Shetty K, Johnson L, Mishra L. Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver. Hepatology 51(4):1373-82, 2010. e-Pub 2010. PMID: 20131405.
173. Andreotti G, Hou L, Gao YT, Brinton LA, Rashid A, Chen J, Shen MC, Wang BS, Han TQ, Zhang BH, Sakoda LC, Fraumeni JF, Hsing AW. Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China. Br J Cancer 102(7):1185-1189, 2010. e-Pub 2010. PMID: 20216539.
174. Meyer TE, O'Brien TG, Andreotti G, Yu K, Li Q, Gao YT, Rashid A, Shen MC, Wang BS, Han TQ, Zhang BH, Niwa S, Fraumeni JF, Hsing AW. Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiol Biomarkers Prev 55(3):1098-1105, 2010. e-Pub 2010. PMID: 20200439.
175. Asran M, Rashid A, Szklaruk J. Hepatic endometriosis mimicking metastatic disease: a case report and review of the literature. J Radiol Case Rep 4(11):26-31, 2010. e-Pub 2010. PMID: 22470699.
176. Meyer TE, O’Brien TG, Andreotti G, Yu K, Li Q, Gao YT, Rashid A, Shen MC, Wang BS, T-Q H, Zhang BH, Niwa S, Fraumeni Jr JF, Hsing AW. Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiology, Biomarkers and Prevention 19:787-793, 2010. e-Pub 2010.
177. W-J W, W-H X, C-Z L, Rashid A, J-R C, Liao P, Hu H, Chu LW, Gao YT, Yu K, Hsing AW. Identification of serum biomarkers for biliary tract cancers by a proteomic approach based on time-of-flight mass spectometry. Cancers 2:1602-1616, 2010. e-Pub 2010.
178. Bell D, Kupferman ME, Williams MD, Rashid A, El-Naggar AK. Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype. Hum Pathol 40(12):1798-1802, 2009. e-Pub 2009. PMID: 19695679.
179. Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol 22(12):1612-21, 2009. e-Pub 2009. PMID: 19734842.
180. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 174(5):1940-1948, 2009. e-Pub 2009. PMID: 19342367.
181. Ricks AM, Han LY, Rashid A, Frumovitz M. Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: a case report. J Reprod Med 54(4):259-260, 2009. e-Pub 2009. PMID: 19438170.
182. Park SK, Andreotti G, Sakoda LC, Gao YT, Rashid A, Chen J, Chen BE, Rosenberg PS, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Chanock S, Hsing AW. Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China. Carcinogenesis 30(4):606-14, 2009. e-Pub 2009. PMID: 19168589.
183. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-1585, 2009. e-Pub 2009. PMID: 19156915.
184. Kim MJ, White-Cross JA, Shen L, Issa JP, Rashid A. Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas. Mod Pathol 22(3):442-9, 2009. e-Pub 2009. PMID: 19136926.
185. Andreotti G, Menashe I, Chen J, Chang SC, Rashid A, Gao YT, Han TQ, Sakoda LC, Chanock S, Rosenberg PS, Hsing AW. Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China. Eur J Epidemiol 24(12):763-74, 2009. e-Pub 2009. PMID: 19888660.
186. Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 14(21):7-43-7049, 2008. e-Pub 2008. PMID: 18981001.
187. Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, Broaddus RR, Rashid A, Albarracin CT. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 27(52):6667-78, 2008. e-Pub 2008. PMID: 18663355.
188. Sanchez AA, Wu TT, Prieto VG, Rashid A, Hamilton SR, Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med 132(10):1623-9, 2008. e-Pub 2008. PMID: 18834221.
189. Yao JC, Phan AT, Chang DZ, Wolff RA, Hess K, Gupta S, Jacobs C, Mares JE, Landgraf AN, Rashid A, Meric-Bernstam F. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. J Clin Oncol 26(26):4311-8, 2008. e-Pub 2008. PMID: 18779618.
190. Hsing AW, Sakoda LC, Rashid A, Chen J, Shen MC, Han TQ, Wang BS, Gao YT. Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 99(5):811-5, 2008. e-Pub 2008. PMID: 18728671.
191. Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 2008. e-Pub 2008. PMID: 18670347.
192. Hsing AW, Sakoda LC, Rashid A, Andreotti G, Chen J, Wang BS, Shen MC, Chen BE, Rosenberg PS, Zhang M, Niwa S, Chu L, Welch R, Yeager M, Fraumeni JF, Gao YT, Chanock SJ. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 68(15):6442-52, 2008. e-Pub 2008. PMID: 18676870.
193. Zhang M, Huang WY, Andreotti G, Gao YT, Rashid A, Chen J, Sakoda LC, Shen MC, Wang BS, Chanock S, Hsing AW. Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Epidemiol Biomarkers Prev 17(8):2123-2127, 2008. e-Pub 2008. PMID: 18708406.
194. Chang SC, Rashid A, Gao YT, Andreotti G, Shen MC, Wang BS, Han TQ, Zhang BH, Sakoda LC, Leitzmann MF, Chen BE, Rosenberg PS, Chen J, Chanock SJ, Hsing AW. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 29(5):944-8, 2008. e-Pub 2008. PMID: 18375961.
195. Andreotti G, Chen J, Gao YT, Rashid A, Chang SC, Shen MC, Wang BS, Han TQ, Zhang BH, Danforth KN, Althuis MD, Hsing AW. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer 122(10):2322-9, 2008. e-Pub 2008. PMID: 18076041.
196. Qian X, Huang C, Cho CH, Hui WM, Rashid A, Chan AO. E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. Cancer Lett 263(1):107-13, 2008. e-Pub 2008. PMID: 18249489.
197. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res 14(9):2560-9, 2008. e-Pub 2008. PMID: 18451217.
198. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF, O'Brien TR, Gao YT. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 122(8):1849-53, 2008. e-Pub 2008. PMID: 18076042.
199. Andreotti G, Chen J, Gao YT, Rashid A, Chen BE, Rosenberg P, Sakoda LC, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Welch R, Chanock S, Fraumeni JF, Hsing AW. Polymorphism of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 17(3):525-34, 2008. e-Pub 2008. PMID: 18296645.
200. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 112(5):1020-7, 2008. e-Pub 2008. PMID: 18205187.
201. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC, Ressom HW, Rashid A, He AR, Mendelson JS, Jessup JM, Shetty K, Zasloff M, Mishra B, Reddy EP, Johnson L, Mishra L. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A 105(7):2445-50, 2008. e-Pub 2008. PMID: 18263735.
202. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 112(3):503-10, 2008. e-Pub 2008. PMID: 18072264.
203. Wei C, Amos CI, Zhang N, Wang X, Rashid A, Walker CL, Behringer RR, Frazier ML. Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling. Clin Cancer Res 14(4):1167-71, 2008. e-Pub 2008. PMID: 18281551.
204. Kim do H, Nagano Y, Choi IS, White JA, Yao JC, Rashid A. Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors. Genes Chromosomes Cancer 47(1):84-92, 2008. e-Pub 2008. PMID: 17943967.
205. Huang WY, Gao YT, Rashid A, Sakoda LC, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Chen BE, Rosenberg PS, Chanock SJ, Hsing AW. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 29(1):100-5, 2008. e-Pub 2008. PMID: 17984110.
206. Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB. Population-based study of islet cell carcinoma. Ann Surg Oncol 14(12):3492-500, 2007. e-Pub 2007. PMID: 17896148.
207. Patel PR, Yao JC, Hess K, Schnirer I, Rashid A, Ajani JA. Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer. Cancer 110(10):2186-90, 2007. e-Pub 2007. PMID: 17896785.
208. Kitisin K, Ganesan N, Tang Y, Jogunoori W, Volpe EA, Kim SS, Katuri V, Kallakury B, Pishvaian M, Albanese C, Mendelson J, Zasloff M, Rashid A, Fishbein T, Evans SR, Sidawy A, Reddy EP, Mishra B, Johnson LB, Shetty K, Mishra L. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene 26(50):7103-10, 2007. e-Pub 2007. PMID: 17546056.
209. Thomas MB, Chadha R, Glover K, Wang X, Morris J, Brown T, Rashid A, Dancey J, Abbruzzese JL. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer 110(5):1059-67, 2007. e-Pub 2007. PMID: 17623837.
210. Van Buren G, Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Somcio R, Fan F, Camp ER, Yao JC, Ellis LM. The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res 13(16):4704-12, 2007. e-Pub 2007. PMID: 17699847.
211. Choi IS, Estecio MR, Nagano Y, Kim do H, White JA, Yao JC, Issa JP, Rashid A. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol 20(7):802-10, 2007. e-Pub 2007. PMID: 17483816.
212. Nagano Y, Kim do H, Zhang L, White JA, Yao JC, Hamilton SR, Rashid A. Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis. Endocr Relat Cancer 14(2):483-92, 2007. e-Pub 2007. PMID: 17639061.
213. Zhang J, Jia Z, Li Q, Wang L, Rashid A, Zhu Z, Evans DB, Vauthey JN, Xie K, Yao JC. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer 109(8):1478-86, 2007. e-Pub 2007. PMID: 17340592.
214. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2007. e-Pub 2007. PMID: 17211865.
215. Luthra MG, Ajani JA, Izzo J, Ensor J, Wu TT, Rashid A, Zhang L, Phan A, Fukami N, Luthra R. Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers. Clin Cancer Res 13(3):912-9, 2007. e-Pub 2007. PMID: 17289885.
216. Hsing AW, Gao YT, McGlynn KA, Niwa S, Zhang M, Han TQ, Wang BS, Chen J, Sakoda LC, Shen MC, Zhang BH, Deng J, Rashid A. Biliary tract cancer and stones in relation to chronic liver conditions: a population-based study in Shanghai, China. Int J Cancer 120(9):1981-1985, 2007. e-Pub 2007. PMID: 17278101.
217. Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31(1):58-64, 2007. e-Pub 2007. PMID: 17197919.
218. Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res 13(1):234-40, 2007. e-Pub 2007. PMID: 17200360.
219. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BS, Niwa S, Chen J, Jr FJ. Gallstones and the risk of biliary tract cancer: a population-based study in Shanghai, China. British Journal of Cancer 97:1577-1582, 2007. e-Pub 2007.
220. Hsing AW, Bai Y, Andreotti, G, Rashid A, Deng J, Chen J, Goldstein AM, T-Q H, M-C S, Jr FJ, Gao YT. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study. International Journal of Cancer 121:832-838, 2007. e-Pub 2007.
221. Wei C, Amos CI, Stephens LC, Campos I, Deng JM, Behringer RR, Rashid A, Frazier ML. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. Cancer Res 65(24):11297-11303, 2006. e-Pub 2006. PMID: 16357136.
222. Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW, Ajani JA. Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Cancer 107(11):2576-80, 2006. e-Pub 2006. PMID: 17075877.
223. Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107(7):1467-74, 2006. e-Pub 2006. PMID: 16955509.
224. Chan AO, Huang C, Hui WM, Cho CH, Yuen MF, Lam SK, Rashid A, Wong BC. Stability of E-cadherin methylation status in gastric mucosa associated with histology changes. Aliment Pharmacol Ther 24(5):831-6, 2006. e-Pub 2006. PMID: 16918887.
225. Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR, Alberts DS, Hamilton SR. Association of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev 15(8):1443-50, 2006. e-Pub 2006. PMID: 16896030.
226. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12(15):4598-604, 2006. e-Pub 2006. PMID: 16899607.
227. Zhu J, Rashid A, Cleary K, Abbruzzese JL, Friess H, Takahashi S, Shirai T, Li D. Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)-DNA adducts in human pancreatic tissues. Biomarkers 11(4):319-28, 2006. e-Pub 2006. PMID: 16908439.
228. Rashid A, Xu J, Gao Y, Rashid A, Zheng SL, Sakoda LC, Shen M, Wang B, Deng J, Han T, Zhang B, Meyers DA, Fraumeni Jr JF, Hsing AW. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Int J Cancer 118(11), 2006. e-Pub 2006. PMID: 16381022.
229. Zhang XH, Andreotti G, Gao YT, Deng J, Liu E, Rashid A, Wu K, Sun L, Sakoda LC, Cheng JR, Shen MC, Wang BS, Han TQ, Zhang BH, Gridley G, Fraumeni JF, Hsing AW. Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China. Int J Cancer 118(12):3089-94, 2006. e-Pub 2006. PMID: 16395699.
230. Hou L, Xu J, Gao YT, Rashid A, Zheng SL, Sakoda LC, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Meyers DA, Fraumeni JF, Hsing AW. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Int J Cancer 118(11):2847-53, 2006. e-Pub 2006. PMID: 16381022.
231. Sakoda LC, Gao YT, Chen BE, Chen J, Rosenberg PS, Rashid A, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Cohen-Webb H, Yeager M, Welch R, Chanock S, Fraumeni JF, Hsing AW. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27(6):1251-6, 2006. e-Pub 2006. PMID: 16361272.
232. Yang AS, Doshi KD, Choi SW, Mason JB, Mannari RK, Gharybian V, Luna R, Rashid A, Shen L, Estecio MR, Kantarjian HM, Garcia-Manero G, Issa JP. DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. Cancer Res 66(10):5495-503, 2006. e-Pub 2006. PMID: 16707479.
233. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 55(4):463-8, 2006. e-Pub 2006. PMID: 16428266.
234. Katuri V, Tang Y, Li C, Jogunoori W, Deng C, Rashid A, Sidawy A, Evans S, Reddy E, Mishra B, Mishra L. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression. Oncogene 25(13):1871-86, 2006. e-Pub 2006. PMID: 16288220.
235. Katuri V, Tang Y, Li C, Jogunoori W, Deng CX, Rashid A, Sidawy AN, Evans S, Reddy EP, Mishra B, Mishra L. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression. Oncogene 25(13):1871-86, 2006. e-Pub 2006. PMID: 16288220.
236. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 2006. e-Pub 2006. PMID: 16456809.
237. Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24(2):259-67, 2006. e-Pub 2006. PMID: 16344314.
238. Tang LP, Cho CH, Hui WM, Huang C, Chu KM, X Xia HH, Lam SK, Rashid A, Y Wong BC, On Chan AO. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer. Digestion 74(2):85-90, 2006. e-Pub 2006. PMID: 17139167.
239. Shao C, Gao YT, Cheng J, Deng J, Wang BS, Shen MC, Han TQ, Zhang BH, Rashid A, Hsing AW. A population-based case-control study on serum lipids in relation to biliary tract cancer and cholelithiasis in Shanghai, China. Tumor (Shanghai) 33:814-824, 2006. e-Pub 2006.
240. Tang LP, Cho CH, Hui WM, Huang C, Chu KM, Xia HH, Lam SK, Rashid A, Wong BC, Chan AO. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer. Digestion 74(2):85-90, 2006. e-Pub 2006. PMID: 17139167.
241. Liu L, Broaddus RR, Yao JC, Xie S, White JA, Wu T, Hamilton SR, Rashid A. Epigenetic alterations in pancreatic endocrine tumors and carcinoid tumors: methylation of ras-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol 18(12):1632-40, 2005. e-Pub 2005.
242. Katuri V, Tang Y, Marshall B, Rashid A, Jogunoori W, Volpe EA, Sidawy AN, Evans S, Blay J, Gallicano G, Reddy E, Mishra L, Mishra B. Inactivation of ELF/TGF- signaling in human gastrointestinal cancer. Oncogene 24(54):8012-24, 2005. e-Pub 2005. PMID: 16158060.
243. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, Mokhtar N, Al-Masri N, Ozbek U, Yaghan R, Kandilci A, Omar S, Kapran Y, Dizdaroglu F, Bondy ML, Amos CI, Issa JP, Levin B, Hamilton SR. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res 11(23):8281-7, 2005. e-Pub 2005. PMID: 16322286.
244. Katuri V, Tang Y, Marshall B, Rashid A, Jogunoori W, Volpe EA, Sidawy AN, Evans S, Blay J, Gallicano GI, Premkumar Reddy E, Mishra L, Mishra B. Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer. Oncogene 24(54):8012-24, 2005. e-Pub 2005. PMID: 16158060.
245. Liu L, Broaddus RR, Yao JC, Xie S, White JA, Wu TT, Hamilton SR, Rashid A. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol 18(12):1632-40, 2005. e-Pub 2005. PMID: 16258509.
246. Wang GG, Yao JC, Worah S, White JA, Luna R, Wu TT, Hamilton SR, Rashid A. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod Pathol 18(8):1079-1087, 2005. e-Pub 2005. PMID: 15920555.
247. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29(8):1079-85, 2005. e-Pub 2005. PMID: 16006804.
248. Liu E, Sakoda LC, Gao YT, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Fraumeni JF, Jr, Hsing AW. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 14(5):1315-8, 2005. e-Pub 2005. PMID: 15894693.
249. Domont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon JP, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria JC, Vauthey JN. Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol 23(13):3086-93, 2005. e-Pub 2005. PMID: 15860868.
250. Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 166(4):1069-75, 2005. e-Pub 2005. PMID: 15793287.
251. Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103(7):1347-55, 2005. e-Pub 2005. PMID: 15719440.
252. Wang BS, Qin J, Deng J, Zhang BH, Han TQ, Shen MC, Rashid A, Hsing AW, Gao YT. A survey on the diagnosis and treatment of biliary tract cancers in Shanghai]. Zhonghua Wai Ke Za Zhi 43(7):455-9, 2005. e-Pub 2005. PMID: 15854373.
253. Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki RR, Rashid A, Hamilton SR, Wu TT. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11(6):2229-36, 2005. e-Pub 2005. PMID: 15788671.
254. Yom SS, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol 18(3):315-9, 2005. e-Pub 2005. PMID: 15492756.
255. Davis DW, Takamori R, Raut CP, Xiong HQ, Herbst RS, Stadler WM, Heymach JV, Demetri GD, Rashid A, Shen Y, Wen S, Abbruzzese JL, McConkey DJ. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668. Clin Cancer Res 11(2 Pt 1):678-89, 2005. e-Pub 2005. PMID: 15701856.
256. An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, Ajani JA, Rashid A, Hamilton SR, Wu TT. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 11(2 Pt 1):656-63, 2005. e-Pub 2005. PMID: 15701853.
257. Zhang X, Gao YT, Rashid A, Deng J, Cheng J, Liu E, Wu K, Sun L, Cheng JR, Gridley G, Hsing AW. Number of pregnancies and risk of biliary tract cancer: a population-based case-control study in Shanghai, China. Tumor (Shanghai) 25:72-75, 2005. e-Pub 2005.
258. Zhang X, Gao YT, Rashid A, Deng J, Liu E, Wu K, Sun L, Cheng JR, Gridley G, Hsing AW. Body mass index and waist-to-hip ratio and risk of biliary tract cancer: a population-based case-control study in Shanghai. Chinese J Clinical Oncology 32:227-230, 2005. e-Pub 2005.
259. Zhang XH, Gao YT, Rashid A, Deng J, Liu EJ, Wu K, Sun L, Cheng JR, Gridley G, Hsing AW. Tea consumption and risk of biliary tract cancers and gallstone disease: a population-based case-control study in Shanghai, China. Zhonghua Zhong Liu Za Zhi 27:667-671, 2005. e-Pub 2005.
260. Zhang X, Gao YT, Deng J, Cheng J, Liu EJ, Wu K, Sun L, Rashid A, Gridley G, Hsing AW. Diet and risk of gallbladder cancer: a population-based case-control study in Shanghai, China. Tumor (Shanghai) 25:351-356, 2005. e-Pub 2005.
261. Mishra B, Tang Y, Katuri V, Fleury T, Said AH, Rashid A, Jogunoori W, Mishra L. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis. Liver Int 24(6):637-45, 2004. e-Pub 2004. PMID: 15566516.
262. Persad R, Liu C, Wu TT, Houlihan PS, Hamilton SR, Diehl AM, Rashid A. Overexpression of caspase-3 in hepatocellular carcinomas. Mod Pathol 17(7):861-7, 2004. e-Pub 2004. PMID: 15098015.
263. Faria SC, Iyer RB, Rashid A, Ellis L, Whitman GJ. Desmoid tumor of the small bowel and the mesentery. AJR Am J Roentgenol 183(1):118, 2004. e-Pub 2004. PMID: 15208123.
264. Faria SC, Iyer RB, Rashid A, Whitman GJ. Hepatic adenoma. AJR Am J Roentgenol 182(6):1520, 2004. e-Pub 2004. PMID: 15149999.
265. Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, Juhng SW, Rashid A, Hamilton SR, Wu TT. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23(26):4646-54, 2004. e-Pub 2004. PMID: 15064707.
266. McGregor DK, Wu TT, Rashid A, Luthra R, Hamilton SR. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol 28(6):712-8, 2004. e-Pub 2004. PMID: 15166663.
267. Ueki T, Hsing AW, Gao YT, Wang BS, Shen MC, Cheng J, Deng J, Fraumeni JF, Jr, Rashid A. Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. Clin Cancer Res 10(5):1717-25, 2004. e-Pub 2004. PMID: 15014024.
268. Maru D, Wu TT, Canada A, Houlihan PS, Hamilton SR, Rashid A. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas. Oncogene 23(3):859-64, 2004. e-Pub 2004. PMID: 14647445.
269. Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A, Vauthey JN. Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11(1):45-51, 2004. e-Pub 2004. PMID: 14699033.
270. Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 17(1):38-43, 2004. e-Pub 2004. PMID: 15209739.
271. Zhang X, Gao YT, Rashid A, Deng J, Liu E, Wu K, Sun L, Cheng JR, Gridley G, Hsing AW. [Cigarette smoking, alcohol consumption and risk of biliary tract cancer: a population-based case-control study in Shanghai, China. Zhongliu Frangzhi Yanjiu]. Cancer Prevention (China) 31:597-604, 2004. e-Pub 2004.
272. Wei C, Amos CI, Rashid A, Sabripour M, Nations L, McGarrity TJ, Frazier ML. Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome. J Histochem Cytochem 51(12):1665-72, 2003. e-Pub 2003. PMID: 14623934.
273. Stancu M, Wu TT, Wallace C, Houlihan PS, Hamilton SR, Rashid A. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol 16(12):1189-98, 2003. e-Pub 2003. PMID: 14681318.
274. Choi HR, Sturgis EM, Rashid A, DeMonte F, Luna MA, Batsakis JG, El-Naggar AK. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol 34(11):1101-7, 2003. e-Pub 2003. PMID: 14652810.
275. Kim SG, Wu TT, Lee JH, Yun YK, Issa JP, Hamilton SR, Rashid A. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Pathol 16(11):1086-94, 2003. e-Pub 2003. PMID: 14614047.
276. Frazier ML, Xi L, Zong J, Viscofsky N, Rashid A, Wu EF, Lynch PM, Amos CI, Issa JP. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res 63(16):4805-8, 2003. e-Pub 2003. PMID: 12941799.
277. Kim SG, Chan AO, Wu TT, Issa JP, Hamilton SR, Rashid A. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. Gastroenterology 124(5):1300-10, 2003. e-Pub 2003. PMID: 12730870.
278. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52(4):502-6, 2003. e-Pub 2003. PMID: 12631658.
279. Shen L, Kondo Y, Hamilton SR, Rashid A, Issa JP. P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124(3):626-33, 2003. e-Pub 2003. PMID: 12612901.
280. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162(3):815-22, 2003. e-Pub 2003. PMID: 12598316.
281. Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR, Rashid A. CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22(6):924-34, 2003. e-Pub 2003. PMID: 12584572.
282. Qian Z, Wang B, Deng J, Zhang B, Han TQ, M-C S, Qin J, Rashid A, Hsing AW, Y-T G. Clinical analysis of 195 cases of bile duct carcinoma in urban Shanghai. Theory and Practice of Surgery 8:107-110, 2003. e-Pub 2003.
283. Rashid A, Ueki T, Gao YT, Houlihan PS, Wallace C, Wang BS, Shen MC, Deng J, Hsing AW. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res 8(10):3156-63, 2002. e-Pub 2002. PMID: 12374683.
284. Herbst RS, Mullani NA, Davis DW, Hess KR, McConkey DJ, Charnsangavej C, O'Reilly MS, Kim HW, Baker C, Roach J, Ellis LM, Rashid A, Pluda J, Bucana C, Madden TL, Tran HT, Abbruzzese JL. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. J Clin Oncol 20(18):3804-14, 2002. e-Pub 2002. PMID: 12228200.
285. Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Rashid A, Hamilton SR, Wu TT. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161(2):611-8, 2002. e-Pub 2002. PMID: 12163385.
286. Kabbani W, Houlihan PS, Luthra R, Hamilton SR, Rashid A. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol 15(6):599-605, 2002. e-Pub 2002. PMID: 12065772.
287. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 160(5):1823-30, 2002. e-Pub 2002. PMID: 12000733.
288. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, Issa JP. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 94(10):755-61, 2002. e-Pub 2002. PMID: 12011226.
289. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20(6):1527-36, 2002. e-Pub 2002. PMID: 11896101.
290. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160(2):529-36, 2002. e-Pub 2002. PMID: 11839573.
291. Yao JC, Schnirer, II, Reddy S, Chiang S, Najam A, Yu C, Giacco G, Hess K, Rashid A, Xie K, Lynch P, Ajani JA. Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer 5(4):208-12, 2002. e-Pub 2002. PMID: 12491078.
292. Chan AO, J-PJ I, Morris JS, hamilton SR, Rashid A. CpG island methylation and the pathogenesis of hyperplastic polyposis. The American Journal of Pathology 160:529-536, 2002. e-Pub 2002.
293. Rashid A, Shen L, Morris JS, Issa JP, Hamilton SR. CpG island methylation in colorectal adenomas. Am J Pathol 159(3):1129-35, 2001. e-Pub 2001. PMID: 11549606.
294. Giles FJ, Kantarjian HM, Kornblau SM, Thomas DA, Garcia-Manero G, Waddelow TA, David CL, Phan AT, Colburn DE, Rashid A, Estey EH. Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation. Cancer 92(2):406-13, 2001. e-Pub 2001. PMID: 11466696.
295. Su LK, Abdalla EK, Law CH, Kohlmann W, Rashid A, Vauthey JN. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 92(2):332-9, 2001. e-Pub 2001. PMID: 11466687.
296. Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol 25(5):637-44, 2001. e-Pub 2001. PMID: 11342776.
297. Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, Fraumeni JF, Jr, Hsing AW. Beta-catenin mutations in biliary tract cancers: a population-based study in China. Cancer Res 61(8):3406-9, 2001. e-Pub 2001. PMID: 11309300.
298. Babar MM, Rashid A, Shahnawaz, Jan M, Munir M, Haider Z. Rational prescription of medicines--a study of indoor patients at a tertiary care hospital. J Ayub Med Coll Abbottabad 13(2):17-8, 2001. e-Pub 2001. PMID: 11732214.
299. Zhang W, Rashid A, Wu H, Xu XC. Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues. J Cancer Res Clin Oncol 127(4):237-42, 2001. e-Pub 2001. PMID: 11315258.
300. Biswas D, Somnath Saha M, Rashid A, Nandi TK. Juvenile nasopharyngeal angiofibromas with unique extrapharyngeal extensions. Indian J Otolaryngol Head Neck Surg 53(2):176-8, 2001. e-Pub 2001. PMID: 23119789.
301. Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 158(2):527-35, 2001. e-Pub 2001. PMID: 11159189.
302. Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S, James SP, Wilson KT, Herman JG, Meltzer SJ. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 20(3):329-35, 2001. e-Pub 2001. PMID: 11313962.
303. Monga SPS, Tang Y, Candotti F, Rashid A, Wildner O, Mishra B, Iqbal S, Mishra L. Expansion of Hepatic and Hematopoietic Stem Cells Utilizing Mouse Embryonic Liver Explants. Cell Transplant 10(1):81-89, 2001. e-Pub 2001. PMID: 28880670.
304. Monga SP, Tang Y, Candotti F, Rashid A, Wildner O, Mishra B, Iqbal S, Mishra L. Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explants. Cell Transplant 10(1):81-9, 2001. e-Pub 2001. PMID: 11294475.
305. Taber KH, Rashid A, Hurley RA. Functional anatomy of central pain. J Neuropsychiatry Clin Neurosci 13(4):437-40, 2001. e-Pub 2001. PMID: 11748313.
306. Rashid A, Watkinson M. Suxamethonium is safe in safe hands; mivacurium should also be considered. Arch Dis Child Fetal Neonatal Ed 83(2):F160-1, 2000. e-Pub 2000. PMID: 11012272.
307. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119(2):323-32, 2000. e-Pub 2000. PMID: 10930367.
308. Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 16(4):663-76, 2000. e-Pub 2000. PMID: 10717233.
309. Lim TO, Ding LM, Goh BL, Zaki M, Suleiman AB, Maimunah AH, Rozita H, Rashid A. Distribution of blood pressure in a national sample of Malaysian adults. Med J Malaysia 55(1):90-107, 2000. e-Pub 2000. PMID: 11072495.
310. Ip-Yam PC, Thomas SD, Jackson M, Rashid A, Behl S. Effects of temperature strategy during cardiopulmonary bypass on cerebral oxygen balance. J Cardiovasc Surg (Torino) 41(1):1-6, 2000. e-Pub 2000. PMID: 10836213.
311. Thompson MP, Kaslow NJ, Kingree JB, Rashid A, Puett R, Jacobs D, Matthews A. Partner violence, social support, and distress among inner-city African American women. Am J Community Psychol 28(1):127-43, 2000. e-Pub 2000. PMID: 10824277.
312. Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J Hepatobiliary Pancreat Surg 7(4):426-31, 2000. e-Pub 2000. PMID: 11180865.
313. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. Jama 282(17):1659-64, 1999. e-Pub 1999. PMID: 10553793.
314. Revelon G, Rashid A, Kawamoto S, Bluemke DA. Primary sclerosing cholangitis: MR imaging findings with pathologic correlation. AJR Am J Roentgenol 173(4):1037-42, 1999. e-Pub 1999. PMID: 10511174.
315. Rashid A, Zahurak M, Goodman SN, Hamilton SR. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 44(6):826-33, 1999. e-Pub 1999. PMID: 10323885.
316. Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, Pitt HA, Sidransky D. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. J Surg Res 84(1):88-93, 1999. e-Pub 1999. PMID: 10334895.
317. Rashid A, Wang JS, Qian GS, Lu BX, Hamilton SR, Groopman JD. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer 80(1-2):59-66, 1999. e-Pub 1999. PMID: 10389978.
318. Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, Huang CC, Wu TC, Lane MD, Diehl AM. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274(9):5692-700, 1999. e-Pub 1999. PMID: 10026188.
319. Rashid A, T-C W, C-C H, C-H C, Lin HZ, Yang SQ, Lee FYJ, Diehl AM. Mitochondiral proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29:1131-1138, 1999. e-Pub 1999.
320. Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS, Kim H, Jen J, Vogelstein B, Hamilton SR. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 153(4):1063-78, 1998. e-Pub 1998. PMID: 9777938.
321. Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 22(3):293-298, 1998. e-Pub 1998. PMID: 9500770.
322. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 113(1):127-35, 1997. e-Pub 1997. PMID: 9207270.
323. Wu TT, Rezai B, Rashid A, Luce MC, Cayouette MC, Kim C, Sani N, Mishra L, Moskaluk CA, Yardley JH, Hamilton SR. Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am J Pathol 150(3):939-47, 1997. e-Pub 1997. PMID: 9060832.
324. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 21(1):60-9, 1997. e-Pub 1997. PMID: 8990142.
325. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP, Hamilton SR. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150(1):201-8, 1997. e-Pub 1997. PMID: 9006336.
326. Rashid A, Hamiliton SR. Genetic alterations in sporadic and Chrohn's-associated adenocarcinoma of the small intestine. Gastroentoerology 113:127-135, 1997. e-Pub 1997.
327. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML, Piantadosi S, Hamilton SR, Giardiello FM. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 109(3):994-8, 1995. e-Pub 1995. PMID: 7657130.
328. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264(5159):713-6, 1994. e-Pub 1994. PMID: 8171324.
329. Rashid A, Dickersin GR, Rosenthal DI, Mankin H, Rosenberg AE. Rhabdomyosarcoma of the long bone in an adult. A case report and literature review. . International Journal of Surgical Pathology 1:253-260, 1994. e-Pub 1994.
330. Rashid A, Auchincloss H, Jr, Sharon J. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice. J Immunol 148(5):1382-8, 1992. e-Pub 1992. PMID: 1538121.
331. Rashid, A. Production and comparison of anti-CD4 chimeric antibodies for the induction of tolerance in skin allografts in mice. Boston University, 1991. e-Pub 1991.

Invited Articles

1. Gu S, Nguyen BN, Rao S, Li S, Shetty K, Rashid A, Shukla V, Deng CX, Mishra L, Mishra B. Alcohol, stem cells and cancer. Genes and Cancer 8:695-700, 2017. e-Pub 2017.
2. Younes M, Rashid A. The Houston Society of Clinical Pathologists 55th Annual Spring Symposium, April 2014. Arch Pathol Lab Med 139(6):721-2, 2015. e-Pub 2015. PMID: 26030240.
3. Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen W, Bergman MA, Freedman-Cass DA. Occult primary, version 3.2014. Journal of National Comprehensive Cancer Network 12:969-974, 2014. e-Pub 2014.
4. Saliba RM, Couriel DR, Giralt S, Rondon G, Okoroji GJ, Rashid A, Champlin RE, Alousi AM. Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplant 47(1):125-31, 2012. e-Pub 2012. PMID: 21383686.
5. Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton K, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen W. Occult primary. Journal of National Comprehensive Cancer Network 9:1358-1395, 2011. e-Pub 2011.
6. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers MED, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB. Histopathologic diagnosis of chronic graft versus host disease: National Institute of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biology of Blood and Marrow Transplantation 12:31-47, 2006. e-Pub 2006.
7. Ettinger DS, Arnoletti JP, Gockerman JP, Handorf C, Havlin KA, Jacobs CD, Javale M, Kvols L, Lenzi R, Rashid A, Ridge JA, Saltz L, Shulman LN, Sondak VK, Thompson JA, Twardowski P, Zhen W. Occult primary cancer clinical practices guidelines. Journal of National Comprehensive Cancer Network 3:214-233, 2005. e-Pub 2005.
8. Rashid A, Issa JPJ. CpG island methylation in gastroenterological neoplasia: a maturing field. Gastroenterology 127:1578-1588, 2004. e-Pub 2004.
9. Rashid A. Cellular and molecular biology of biliary tract cancer. Surgical Oncology Clinics of North America 11:995-1009, 2002. e-Pub 2002.
10. Rashid A. Gatekeepers, caretakers and landscapers: hamartomas and neoplasms. Histopathology 2:364-367, 2002. e-Pub 2002.
11. Moncure AC Rashid A. Case Records of the Massachusetts General Hospital: a 60-year old man with hypertrophic cardiomyopathy and ischemic colitis. New England Journal of Medicine 332:804-810, 1995. e-Pub 1995.
12. LaMont JT, Rashid A. Case Records of the Massachusetts General Hospital: a 31-month girl with fever, diarrhea, abdomial distention, and edema. New England Journal of Medicine 330:420-426, 1994. e-Pub 1994.

Review Articles

1. Yavuz BG, Pestana RC, Abugabal YI, Krishnan S, Chen J, Hassan MM, Wolff RA, Rashid A, Amin HM, Kaseb AO. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma. Oncotarget 11(13):1186-1201, 2020. e-Pub 2020. PMID: 32284794.
2. Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?. Onco Targets Ther 10:1403-1412, 2017. e-Pub 2017. PMID: 28424556.
3. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063-72, 2008. e-Pub 2008. PMID: 18565894.
4. Chan AO, Rashid A. CpG island methylation in precursors of gastrointestinal malignancies. Curr Mol Med 6(4):401-8, 2006. e-Pub 2006. PMID: 16900663.
5. Rashid A. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 11(4):995-1009, 2002. e-Pub 2002. PMID: 12607585.
6. Rashid A. Gatekeepers, caretakers, and landscapers: hamartomas and neoplasms. Histopathology(2):364-367. e-Pub 2002.
7. Rashid A, Lehrman S, Romano P, Frishman W, Dobkin J, Reichel J. Primary pulmonary hypertension. Heart Dis 2(6):422-30, 2000. e-Pub 2000. PMID: 11728293.

Professional Educational Materials

1. Raju SG, Mahometano L, Rashid A, Lynch P. Colon cancer prevention: flat lesion and endoscopic mucosal resection, 2011.
2. Raju SG, Mahometano L, Rashid A, Lynch P. Colon cancer prevention: EMR of flat lesion –SSA. DAVE Project Gastroenterology, 2011.
3. Raju SG, Mahometano L, Rashid A, Lynch P. Subtle lesions of colon. DAVE Project Gastroenterology, 2011.

Other Articles

1. Rashid A, Chamseddine S, Tran Cao HS, Xiao L, Hasanov E, Bhosale P, Amin HM, Mohamed YI, Yavuz BG, Sakr Y, Xu L, Hu I, Lee SS, Sakamuri D, Jindal S, Nguyen V, Curran MA, Sun R, Rashid A, Duda DG, Sharma P, Qayyum A, Kaseb AO Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma. Oncology:1-8, 2024. PMID: 39427654.
2. Taggart MW, Rashid A Pathology and immunohistochemistry of hereditary colorectal cancer. Seminars in Colon and Rectal Surgery 22:71-76, 2011.
3. Shen L, Houlihan PS, Robinson R, Rashid A, Hamilton SR, J-PJ I Mapping CpG island methylation in normal mucosa of patients with colon cancer 43:1128.
4. Rashid A, Hess KR, Lenzi R, Raber MN, Abbruzzese JL, Varadhachary GR Overexpression and prevalence of molecular markers in patients with cancer of unknown primary. Annual Meeting of the American Society of Clinical Oncology.
5. I-S C, An C, Swisher SG, Correa AM, Ajani JA, Rashid A, Hamilton SR, T-T W Frequent CpG island methylation in resected esophageal adenocarcinomas. Proceedings: 96th Annual Meeting of the American Association for Cancer Research.
6. Wang H, Wang H, Yao J, Wu TT, Zhang W, Hamilton SR, Rashid A Expression of IGFBP2 in carcinoid tumors and pancreatic endocrine tumors. Modern Pathology.
7. Vuong MP, Choi H, Rashid A, Broemeling LD, Vauthey JN, Ma J Quantitation of hepatic steatosis in oncologic patients using a fast dual-echo Dixon technique. International Society of Magnetic Resonance in Medicine 14th Meeting.
8. Wang KL, Liu L, Yao JC, Wang H, Rashid A, Hamilton SR, Wu TT Prevalence and clinicopathologic features of colorectal high-grade neuroendocrine carcinomas associated with overlying adenoma. Modern Pathology.
9. May SA, Wang H, Fuller GN, Wu TT, Rashid A, Hamilton SR, Wang H Activation of c-Jun NH-2 terminal kinases (JNKs) correlates with the histologic grades and EGFR receptor expression in diffuse gliomas. Modern Pathology.

Abstracts

1. Wang M, Estrella JS, Katz MH, Rashid A, Lee JE, Maitra A, Wolff RA, Varadhachary GR, Wang H. Expression of epithelial-mesenchymal transition markers (EMT) in treated pancreatic ductal adenocarcinoma. Cancer Research 78(13 Supplement):1547. e-Pub 2018.
2. Abbott SE, Broaddus R, Routbort MJ, Roy-Chowdhuri S, Yemelyanova A, Rashid A, Luthra R, Patel KP, Chen H. Next-generation sequencing for the detection of actionable genetic alterations in advanced breast cancer: should we be testing and how?. Journal of Molecular Diagnostics 20:1002. e-Pub 2018.
3. Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff R, Lee J, Maitra A, Fleming JB, Rashid A, Wang H. Prognostic significance of new AJCC tumor (T) stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. Modern Pathology 30(442A). e-Pub 2017.
4. Samdani R, Tetzlaff MT, Curry JL, Ning J, Piao J, Aung PP, Torres-Cabala CA, Ivan D, Wang WL, Lazar AJ, Ross MI, Royal RE, Wargo JA, Gershenwald JE, Davies MA, Prieto VG, Rashid A, Nagarajan P. Primary anorectal melanoma: a retrospective analysis of 30 patients. Modern Pathology 30(135A-136A). e-Pub 2017.
5. Raju GS, Lum P, Ross W, Lynch PM, Miller E, Thirumurthi S, Blechacz B, Lee JH, Shafi M, Bhutani MS, Rashid A, Weston BR, Davila ML, Stroehlein J. Outcome of a protocol driven endoscopic resection of patients with large colon polyps (.20 mm) results in low complications and recurrence. Gastrointestinal Endoscopy. e-Pub 2017.
6. Hui L, Katz MH, Rashid A, Foo WC, Sundar M, Lee JE, Tamm EP, Fleming JB, Wang H. Significance of T1a and T1b carcinoma arising in mucinous cystic neoplasm of pancreas. Modern Pathology 30(445A). e-Pub 2017.
7. Yemelyanova A, Routbort MJ, Chen H, Rashid A, Roy-Chowdhuri S, Lazar AJ, Manekia J, Mohammad M, Mantha G, Singh RR, Luthra R, Medeiroes JL, Patel KP. Tumor in normal or normal in tumor: what to do when somatic mutations are detected in “normal” germline control used for NGS-based targeted somatic mutation testing. Journal of Molecular Diagnostics 18:1027. e-Pub 2017.
8. Liu QQ, Stewart JM, Wang H, Rashid A, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang HM. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy and pancreaticoduodenectomy. Modern Pathology 29(183A). e-Pub 2016.
9. Nejati R, Halperin DM, Goldstein JB, Wang H, Rashid A, Katz MH, Lee JE, Fleming JB, Canales JR, Blando J, Wistuba II, Maitra A, Wolff RA, Varadhachary GR, Wang HM. The prognostic significance of infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. Modern Pathology 29(189A). e-Pub 2016.
10. Ertem FU, Dashwood WM, Rajendran P, Raju G, Rashid A, Dashwood R. Novel polpectomy system in a preclinical model of colon cancer. Cancer Research 76(14s):839. e-Pub 2016.
11. Van Dyke AL, Kemp TJ, Corbel AF, Zhu B, Y-T G, Wang B, Rashid A, Shen MC, Hildescheim A, Hsing AW, Pinto LA, Koshiol J. Associations between lipopolysaccharide (LPS) and lipopolysaccharide-pathway biomarkers and gallbladder cancer are modulated by markers of systemic inflammation. Cancer Research 76(14S):3441. e-Pub 2016.
12. Chen J, Shukla V, Chen JS, Panditab RK, Jeong YS, Katz LH, Shin JH, Gi Y, Kwongc LN, Huntb CR, Farci P, Su XP, White J, Mishra B, Rashid A, Javle M, Li L, Chen JJ, Stroehlein J, Davilla M, Akbani R, Machidao K, Tsukamoto H, Pandita TK, Mishra L. The TGF-beta effector beta 2SP depletion abrogates DNA damage repair. Cancer Research 76(14S):3594. e-Pub 2016.
13. Lee S, Broaddus RR, Pattanaprichaku P, Singh RR, Routbort M, Patel KP, Luthra R, Rashid A, Chen H. Molecular characterization of appendiceal mucinous neoplasms: stratification of KRAS, GNAS, and TP53 mutations by tumor grade. Journal of Molecular Diagnostics 18(1001):1001. e-Pub 2016.
14. Olar A, Broaddus R, Routbort M, Roy-Chowdhuri S, Hodges KB, Singh RR, Lazar AJ, Rashid A, Chen H, Yemelyanova A, Medeiroes JL, Hamilton SR, Luthra R, Patel KP. Value of paired tumor-normal analysis in solid tumor genotyping by next-generation sequencing. Journal of Molecular Diagnostics 18:1005. e-Pub 2016.
15. Chen H, Routbort MJ, Rashid A, Roy-Chowdhuri S, Patel KP, Lazar A, Broaddus R, Manekia J, Singh R, Luthra R, Yemelyanova A. Challenges in next-generation sequencing analysis of somatic mutations in transplant patients. Journal of Molecular Diagnostics 18:1022. e-Pub 2016.
16. Roy-Chowdhuri S, Routbort MJ, Singh RR, Broaddus R, Lazar AJ, Rashid A, Chen H, Yemelyanova A, Manekia J, Chen W, Medeiroes JL, Hamilton SR, Luthra R, Patel KP. SNP signature-based sample identification as a patient safety tool in NGS-based targeted oncologic testing. Journal of Molecular Diagnostics 18:1049. e-Pub 2016.
17. Agarwal A, Correa AM, Wang HM, Maru D, Tan DF, Abraham SC, Taggart MW, Estrella JS, Foo WC, Hofstetter WL, Rashid A. Prospectively reported histologic tumor viability score and factors predicting long term survival in patients with trimodality therapy for primary esophageal adenocarcinoma. Modern Pathology 29(159A). e-Pub 2016.
18. Friedman K, Foo WC, Abraham SC, Rashid A, Taggart MW. Appendiceal goblet cell carcinoid tumors - findings after definitive resection. Modern Pathology 29(172A). e-Pub 2016.
19. Jedrzkiewicz J, Foo WC, Mansfield P, Overman M, Rafeeq S, Rashid A, Taggart MW. Conventional colonic-type adenocarcinomas of the appendix: clinicopathologic comparison with cecal adenocarcinomas. Modern Pathology 29(176A). e-Pub 2016.
20. Abdel-Wahab R, Eid SSM, Hassan M, Xiao LC, J-S L, Cheung SH, Hassabo HM, Shalaby AS, Essa HH, Mosad E, Raghav KPS, Rashid A, Wolff, RA, Morris J, Amin HM, Kaseb, AO. International validation of an IGF-CTP scoring system for assessing hepatic reserve in hepatocellular carcinoma. Journal of Clinical Oncology(33s):e15140. e-Pub 2015.
21. Chatterjee D, Katz M, Rashid A, Wang H, Varadhachary G, WolfF R, Lee J, Pisters P, Maitra A, Wang HM. Microscopic invasion in intraductal papillary mucinous neoplasm of pancreas. Modern Pathology 28(440A). e-Pub 2015.
22. Liu L, Katz M, Lee SM, Fisher L, Sundar M, Wang H, Varadhachary G, WolfF R, Lee J, Pisters P, Maitra A, Fleming J, Estrella J, Rashid A, Wang HM. Margin status of posttherapy pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma. Modern Pathology 28(175A). e-Pub 2015.
23. Lee SM, Wang HM, Rashid A, Maitra A, Liu L, Sundar M, Wang H, Katz M, Varadhachary G, Lee JE, Wolff RA, Fleming JB, Pisters P. Histologic grading of tumor response in posttherapy pancreaticoduodenectomies for patients with pancreatic ductal adenocarcinoma. Modern Pathology 28(174A). e-Pub 2015.
24. Agarwal A, Tan DF, Abraham S, Taggart M, Wang H, Estrella J, Zhang M, Rashid A, Maru D. Retrospective study of clinicopathologic features and patient outcome of primary adenosquamous carcinoma of the esophagus. Modern Pathology 28(144A). e-Pub 2015.
25. Anand D, Churi C, Rashid A, Shroff RT, Zuo MX, Conrad C, J-N V, Javle MM. BAP1 mutation-associated cholangiocarcinoma: an aggressive disease. Journal of Clinical Oncology 33(3s):420. e-Pub 2015.
26. Koshiol J, Gao Y, Fox JG, Ljungh, Rashid A, Hildesheim A, Hsing AW. Challenges in the evaluation of Helicobacter species and biliary tract cancer. Helicobacter 20(85). e-Pub 2015.
27. Ok C, Loghavi S, Salim AA, Chen H, Kanagal-Shamanna R, Chowdhuri SR, Broaddus RR, Lazar A, Rashid A, Manekia JH, Barkoh BA, Medeiores L, Singh RR, Routbort MJ, Luthra R, Patel KP. To confirm or not to confirm, that is the question for equivocal NGS findings. Journal of Molecular Diagnostics 17:810. e-Pub 2015.
28. Im JS, Saliba RM, Abraham SC, Ross W, Rondon G, Rashid A, Shpall EJ, Popat UR, Qazilbash M, Hosing CM, Oran B, Shah N, Champlin RE, Alousi AM. Histologic confirmation for patients presenting with gastrointestinal graft-versus-host disease: how to interpret histologic grade 1 (does it matter)?. Blood 126(23). e-Pub 2015.
29. Im JS, Saliba RM, Abraham SC, Rashid A, Ross W, Nieto Y, Shpall EJ, Oran B, Olson A, Ahmed S, Popat UR, Rondon G, Qazilbash MH, Shah N, Champlin RE, Alousi AM. Gastrointestinal acuity score (GAS): a comprehensive risk score incorporating histologic grade and clinical factors to predict need for second line therapy, non-relapse mortality and overall survival in lower gastrointestinal graft-versus-host disease. Blood 126(23). e-Pub 2015.
30. Menon VK, Raju GS, Chen J, Su X, Mistry N, Majumdar A, J-H S, Li S, Shetty K, Wu X, Weston B, Miller E, Stroehlein J, Davila M, Shafi MA, Rashid A, Kallakury BV, Thirumurthi S, McMurray JS, S-H L, Jugunoori W, Mishra L. Genomic and mutational profiling of human colon adenomas reveals early driver mutations and a TGF-β-CEA regulated profile. American Association of Cancer Research. e-Pub 2015.
31. J-H S, Katz LH, Muňoz NM, Cortes A, Shukla V, S-B K, Herlong F, Machida K, Tsukamoto H, Shetty K, He AR, Johnson LB, Rashid A, Chen J, J-S L, Mishra L. Vitamin D deficiency regulates TLR7 to promote hepatocellular cancer in TGF-β/Smad3 heterozygous mice. American Association of Cancer Research. e-Pub 2015.
32. Chen J, J-S C, Yao Z, Jugunoori W, Mishra B, Herlong FH, Jeong YS, Mistry NA, Zhang J, Su X, Rashid A, Davilla M, Stroehlein J, Shay JW, Mishra L. Disruption of TGF-β-regulated CTCF suppression of telomerase links a human stem cell disorder to tumorigenesis. American Association of Cancer Research. e-Pub 2015.
33. Chen J, J-S C, Zhang J, Phan L, Muňoz NM, Katz LH, Gi YJ, Menon VK, J-H S, Jeong YS, Jugunoori W, Farci P, Shetty K, Su X, Pandita TK, White J, Mishra B, Zamboni F, Wu X, Rashid A, Li S, Javle M, M-C H, Herlong F, Davila M, Stroehlein J, Shaw KR, Wang X, Morris JS, Akbani R, Mishra L. Genomic landscape of human cancer reveals dysregulated TGF-β signaling with prognostic significance. American Association of Cancer Research. e-Pub 2015.
34. Jabbar K, Routbort M, Singh C, Rashid A, Broaddus R. Impact of tumor necrosis on success of clinical next generation sequencing. Modern Pathology 28(501A). e-Pub 2015.
35. Fisher L, Katz M, Lee SM, Liu L, Sundar M, Wang H, Varadhachary G, WolfF R, Lee J, Pisters P, Maitra A, Fleming J, Estrella J, Rashid A, Wang HM. Prognostic significance of the number and ratio of positive lymph nodes for patients with pancreatic ductal adenocarcinoma who completed neoadjuvant therapy and pancreaticoduodenectomy. Modern Pathology 28(442A). e-Pub 2015.
36. Ren Z, Hejazi N, Rashid A, Katz M, Wang H, Wolff RA, Abbruzzese JL, Fleming J, Wang H. Comparison of the clinicopathologic features of short and long pancreatic ductal adenocarcinoma survivors after pancreaticoduodenectomy. Modern Pathology 27(453A). e-Pub 2014.
37. Wang H, Estrella JS, Chatterjee D, Katz MH, Rashid A, Wang H, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB. Pancreatic ductal adenocarcinoma: neoadjuvant therapies and pathology. Pathology 2(S25). e-Pub 2014.
38. Voong K, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC, Wolff RA, Skibber JM, Feig BW, Chang GJ, Das P. Radiation therapy for high-grade neuroendocrine carcinoma of the rectum and anal canal. Journal of Radiation Oncology Biology Physics 90(S394). e-Pub 2014.
39. Patel KP, Routbort M, Aldape K, Broaddus R, Lazar A, Chowdhuri SR, Rashid A, Singh R, Zuo Z, Chen H, Shamanna RK, Goswani R, Jabbar J, Barkoh B, Manekia J, Medeiores L, Luthra R. Development of a quality assurance framework for clinical reporting of next-generation sequencing-based molecular oncology testing. Journal of Molecular Diagnostics 16(778). e-Pub 2014.
40. Muňoz NM, Katz LH, Machida K, Tsukamoto H, Shetty K, He AR, Johnson LB, Rashid A, Kim SB, J-S L, Mishra L. Vitamin D deficiency promotes hepatocellular carcinoma tumor growth in TGF-β impaired mice by Smad3 heterogeneous deletion. Cancer Research 74S(248). e-Pub 2014.
41. Majumdar A, Chen J, Lin SH, Katz L, Raju GS, Shetty K, White J, Wu XF, Rashid A, McMurray JS, Shaw KR, Su XP, Weston B, Thirmurthi S, He AR, Mishra L. Genome and Exome analysis of early colon cancer reveals new targets. Cancer Research 74S(4703). e-Pub 2014.
42. Muňoz NM, Katz LH, Gagea MI, Rashid A, Mishra L. Generation of a T-cell lymphoma mouse model based on chronic LPS challenge and TGF-β signaling disruption. Cancer Research 74s(3921). e-Pub 2014.
43. Weng B, Rashid A, Grubbs EG, Lee JE, Wang H. Gastrinomas associated with multiple endocrine neoplasia type 1 syndrome: a clinicopathologic study of 14 cases. Modern Pathology 27(457A). e-Pub 2014.
44. Estrella J, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Modern Pathology 27(448A). e-Pub 2014.
45. Liang L, Rashid A, J-N V, Wang H. Clinicopathologic features of hepatocellular carcinoma with prominent lymphoid stroma. Modern Pathology 27(424A). e-Pub 2014.
46. Xia MD, Overman MJ, Rashid A, Wang H, Katz MH, Fleming JB, Wolff R, Wang H. Expression and clinical significance of EGFR, IGF-1R and HER-2 in patients with ampullary adenocarcinoma. Modern Pathology 27(210A). e-Pub 2014.
47. Patel V, Hofstetter W, Correa A, Agarwal A, Rashid A, Ajani J, Swisher S, Maru D. Signet ring cell histology on pretreatment biopsy predicts poor response and survival outcomes in patients with esophageal adenocarcinoma treated with neoadjuvant chemoradiation and surgery. Modern Pathology 27(197A). e-Pub 2014.
48. Estrella JS, Loghavi S, Fuller GN, Ajani JA, Rashid A. FOXP3+ tumor infiltrating lymphocytes in EBV-positive lymphoepithelioma-like gastric carcinoma: clinicopathologic features and survival. Modern Pathology 27(173A). e-Pub 2014.
49. Estrella JS, Tetzlaff MT, Kazen C, Kopetz S, Maru DM, Rashid A, Hamilton SR, Broaddus R. BRAF V600E immunohistochemistry in colorectal cancer. Modern Pathology 27(173A). e-Pub 2014.
50. Conte B, George B, Dasari A, Overman MJ, Estrella J, Jiang ZQ, Machado K, Mello CL, Ferrarotto R, Hoff PM, Yao JC, Rashid A, Kopetz S. Colorectal high-grade neuroendocrine carcinoma: a single institution experience. Journal of Clinical Oncology 32(S540). e-Pub 2014.
51. Morris VK, Rashid A, Rodriquez-Bigas MA, Das P, Wolff RA, Chang GJ, Crane CH, Phillips J, Ohinata A, Rogers J, Eng C. Association of human papillomavirus with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal. Journal of Clinical Oncology 32(S479). e-Pub 2014.
52. Roland CL, Kang YA, Chatterjee D, Estrella J, Rashid A, Lee JE, Yao JC, Fleming JB. Loss of SMAD4 and effect on overall survival in resected gastrointestinal neuroendocrine tumors. Journal of Clinical Oncology 21(S94). e-Pub 2014.
53. Dasari A, Phan A, Gupta S, Hess KR, Culotta KS, Rashid A, Yeung SJ, Subbiah IM, Meric-Bernstam F, Yao JC. A phase 1 study of anti-IGF-1R monoclonal antibody (MoAb), IMC-A12(I) and everolimus € in well-differentiated neuroendocrine tumors (WD NET). Journal of Clinical Oncology 32(S232). e-Pub 2014.
54. Shroff RT, Churi C, Rashid A, Mishra L, Zuo MX, Kaseb AO, Janku SA, Aloia TA, J-N V, Curley SA, Javle MM. Next-generation sequencing yields promising targets in advanced cholangiocarcinomas (CCA). Journal of Clinical Oncology 32(S209). e-Pub 2014.
55. Guo R, Rashid A, Overman M, Wang H, Abbruzzese J, Wang H. Immunohistochemical study of ampullary and small bowel adenocarcinomas. Modern Pathology 26(152A). e-Pub 2013.
56. Churi C, Rashid A, Shroff RT, Mishra L, Zuo MX, Kaseb A, Janku F, Aloia TA, J-N V, Curley SA, Ali S, Palmer G, Javle MM. Next generation sequencing yields promising targets in advanced cholangiocarcinomas (CCA). Molecular Cancer Therapeutics 12(SB132). e-Pub 2013.
57. Tanasanvimon B, Rashid A, Wongkham S, Churi C, Tong Z, Fogelman DR, Silsrivanit A, Blecacz B, Klaikaew N, Bhudhisawasdi V, J-N V, Javle MM. Comparison of microRNA (MiRNA) expression profiles between Opisthorchis viverrini-associated cholangiocarcinoma (OC-CCA) and non-Opisthorhic viverrini-associated cholangiocarcinomass (non-OV CCA). Journal of Clinical Oncology 31(4s):206. e-Pub 2013.
58. Agarwal A, Chang G, Y-C H, Taggart M, Rashid A, Kopetz S, Maru D. Residual tumor burden in rectal cancer: a new method of assessing pathologic response to neoadjuvant therapy. Modern Pathology 26, 2013. e-Pub 2013.
59. Guo R, Rashid A, Overman M, Wang H, Abbruzzese J, Wang H. Immunohistochemical study of anoullary and small bowel adenocarcinomas. Modern Pathology 26, 2013. e-Pub 2013.
60. Shroff S, Taggart MW, Abraham SC, Rashid A. Intralymphatics tumor in duodenal biopsies: clinicopathologic features. Modern Pathology 26, 2013. e-Pub 2013.
61. Chatterjee D, Katz MH, Rashid A, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Abbruzzese J, Fleming JB, Wang H. Histologic changes in non-neoplastic pancreas after neoadjuvant therapy for pancreatic ductal adenocarcinoma. Modern Pathology 26, 2013. e-Pub 2013.
62. Ma LT, Wang H, Rashid A, Broaddus RR, Estrella JS. Estrogen-induced genes are expressed in pancreatic neuroendocrine tumors. Modern Pathology 26, 2013. e-Pub 2013.
63. Shroff S, Rashid A, Wang H, Katz MH, Lee JE, Abbruzzese J, Fleming JB, Wang H. Sox9: a novel marker for pancreatic centroacinar cell and ductal cell differentiation. Modern Pathology 26, 2013. e-Pub 2013.
64. Javle MM, Rashid A, Kar SP, Schalper K, Wang N, Peto M, J-N V, Aloia TA, De Aretxabala X, Mills GB, Spellman P, Roa I. Identification of unique somatic mutations with functional relevance through genetic characterization of gallbladder cancer. Journal of Clinical Oncology 31(4s):214. e-Pub 2013.
65. Taggart MW, Ross WA, Rashid A, Abraham SC. Esophageal squamous dysplasia – clinical associations and follow-up. Gastroenterology 144(S-517). e-Pub 2013.
66. Zuo M, Rashid A, Churi C, Hung MC, Javle MM. Novel therapeutic strategies targeting the hedgehog signaling pathway and mTOR pathway in biliary tract cancer (BTC). Molecular Cancer Therapeutics 11(SC171). e-Pub 2013.
67. Agarwal A, Chang G, Y-C H, Taggart M, Rashid A, Kopetz S, Maru D. Residual tumor burden in rectal cancer: a new method of assessing pathologic response to neoadjuvant therapy. Modern Pathology 26(141A). e-Pub 2013.
68. Foo W, Rashid A, Wang H, Hamilton S, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Huamin W. Loss of PTEN expression in pancreatic ductal adenocarcinoma is associated with poor survival. Modern Pathology 25(442A). e-Pub 2012.
69. Estrella JS, Taggart MW, Rashid A, Abraham SC. Low grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the beta-catenin/APC pathway. Modern Pathology 25(160A). e-Pub 2012.
70. Shroff S, Rashid A, Mounajjed T, Wu TT, Abraham SC. Gastric chief cell adenoma: proposal for a new entity. Modern Pathology 25(180A). e-Pub 2012.
71. Shroff S, Overman M, Rashid A, Wang H, Shroff R, Hamilton SR, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Huamin W. Loss of PTEN expression is associated with poor prognosis in patients with ampullary adenocarcinoma. Modern Pathology 25(448A). e-Pub 2012.
72. Taggart MW, Rashid A, Estrella JS, Abraham SC. Serrated polyps of the extracolonic gastrointestinal tract: histologic findings and genetic alterations. Modern Pathology 25(182A). e-Pub 2012.
73. Zenali JB, Overman M, Rashid A, Hamilton SR, Broaddus R, Katz MH, Abbruzzese JL, Fleming JB, Huamin W. Clinicopathologic review of 62 cases of primary duodenal adenocarcinoma. Modern Pathology 25(187A). e-Pub 2012.
74. Zhao Q, Weng S, Foo S, Estrella JS, Yao JC, Wang A, Rashid A. Loss of expression of DAXX and ATRX in low-grade neuroendocrine tumors (carcinoid tumors). Modern Pathology 25(187A). e-Pub 2012.
75. Agarwal A, Appleberry T, Guha S, Ajani J, Hofstetter W, Swisher S, Lennon P, Rashid A, Maru D. Novel chromosomal abnormalities in Barrett’s esophagus and esophageal adenocarcinoma identified by array comparative genomic hybridization. Modern Pathology 25(125A). e-Pub 2012.
76. Estrella JS, Broaddus R, Yao JC, Wang H, Rashid A. Combined progesterone receptor and PTEN expression predicts metastasis and survival in patients with pancreatic neuroendocrine tumors. Modern Pathology 25(442A). e-Pub 2012.
77. Dong M, Sangai T, Zhai Q, Rashid A, Meric-Bernstam F, Yao JC. Activation of hedgehog pathway in neuroendocrine tumors. Journal of Clinical Oncology. e-Pub 2012.
78. Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PWT, J-N V, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Huamin W. Histologic grading the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Modern Pathology 25(441A). e-Pub 2012.
79. Estrella JS, Hofstetter W, Correa AM, Ajani J, Swisher S, Rashid A, Maru D. Measurement of depth of invasion, submucosal and lymphovascular invasion (LVI) predicts lymph node (LN) involvement in T1 esophageal adenocarcinoma (EAC). Modern Psychology 24(146A). e-Pub 2011.
80. Goodarzi M, Kanhere R, Corley L, Correa AM, Ajani J, Swisher S, Hofstetter W, Rashid A, Maru D. Sox-9 immunohistochemistry demonstrates abnormal distribution of gastrointestinal stem cells in specialized and non-specialized Barrett’s mucosa. Modern Pathology 24(149A). e-Pub 2011.
81. Estrella JS, Rashid A, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PWT, Abdalla EK, J-N V, Wang H, Gomez HF, Evans DB, Fleming JB, Abbruzzese JL, Wang H. Posttherapy pathologic stage and number of positive lymph nodes predict survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Modern Pathology 24(359A). e-Pub 2011.
82. Zhao Q, Rashid A, Gong Y, Katz M, Lee J, Wolf RA, Charnsangavej C, Varadhachary GR, Pisters P, Abdalla EK, J-N V, Wang H, Gomez H, Fleming JB, Abbruzzese JL, Wang H. Pathologic complete response is associated with good prognosis in patients with pancreatic ductal adenocarcinoma who received neoadjuvant chemoradiation and pancreatectomy. Modern Pathology 24(378A). e-Pub 2011.
83. Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Haddock MG, Erickson B, Willet CG. Efficacy endpoints of RTOG 0247: a randomized phase II study of neoadjuvant capecitabine (C) and ironetecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer. Journal of Clinical Oncology 29s. e-Pub 2011.
84. Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Haddock MG, Erickson B, Willet CG. High-grade neuroendocrine carcinomas (HGNECs) of the colon and rectum: a single-institution retrospective analysis. Journal of Clinical Oncology 29s. e-Pub 2011.
85. Bartley AN, Patel KA, Barkoh BA, Mishra B, Yao H, Rashid A, Luthra R, Hamilton SR. MicroRNA expression during the colorectal adenoma-adenocarcinoma sequence. Modern Pathology 23(136A). e-Pub 2010.
86. Taggart MW, Rashid A, Abraham SC. Esophageal leukoplakia: risk factors and relationship to squamous neoplasia. Modern Pathology 23(170A). e-Pub 2010.
87. Othman ML, Rashid A, Abbruzzesse JL, Wolff RA, Wang H. Expression of aldehyde dehydrogenase is associated with high-grade histology and survival in patients with primary small bowel adenocarcinomas. Modern Pathology 23(160A). e-Pub 2010.
88. Lee JH, Dasari CS, Harvinder S, Rashid A, Bhutani MS, Raju RP, Jaganmohan S, Yao JC, Phan A, Raju GS. Neuroendocrine tumors of gastrointestinal tract and pancreas: diagnostic modalities, accuracy, and outcomes. Gastrointestinal Endoscopy 71(AB285). e-Pub 2010.
89. Estrella JS, Wang H, Taggart MW, Abraham SC, Rashid A. Immunohistochemical expression of progesterone receptor in Neuroendocrine tumors: expression is present predominately in low-grade pancreatic endocrine tumors. Modern Pathology 23(353A). e-Pub 2010.
90. Agarwal A, Sethi S, Lin E, Luthra R, Rashid A, Maru DM. Histologic subtypes of microsatellite instability-high (MSI-H) colorectal adenocarcinomas (CRCs) and their association with clinicopathologic features and prognosis. Modern Pathology 23(134A). e-Pub 2010.
91. Estrella JS, Rashid A, Abraham SC. “In-situ” growth of metastatic tumors to the gastrointestinal tract: a potential mimic of primary neoplasia. Modern Pathology 23(144A). e-Pub 2010.
92. Goodarzi M, Rashid A, Maru DM. Anti-phosphohistone H3 shows differential expression in Barrett’s esophagus, low-grade dysplasia, high-grade dysplasia, adenocarcinoma sequence. Modern Pathology 22(131A). e-Pub 2009.
93. Fang X, Taggart M, Corley L, Wang H, Hamilton SR, Rashid A. Nucleolin expression in colorectal adenocarcinomas: higher nucleolin expression is associated with better prognosis in stage III colorectal cancers. Modern Pathology 22(129A). e-Pub 2009.
94. Maru DM, Singh RR, Hannah C, Albarracian CT, Romans A, Li YX, Abrahams R, Yao H, Luthra MG, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a: a potential marker of progression in Barrett’s esophagus-dysplasia-adenocarcinoma sequence. Modern Pathology 22(139A). e-Pub 2009.
95. Maru DM, Correa AM, Tong Z, Wang H, Wu TT, Corley L, Krishnan S, Ajani JA, Swisher SG, Rashid A, Hofstetter WL, Guha S. Loss of neutrophilic gelatinase associated lipocalin (NGAL) expression in esophageal adenocarcinoma (EAC) is associated with higher pathologic stage and poor survival. Modern Pathology 22(139A). e-Pub 2009.
96. Earle JSL, Romans A, Abraham R, Rashid A, Hamilton S, Luthra R. miRNA expression in colorectal carcinoma: correlation with microsatellite instability. Modern Pathology 21(1117A). e-Pub 2008.
97. Maru DM, Khurana H, Correa AM, Swisher SG, Rashid A, Ajani JA, Hofstetter WL. Clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of esophagus. Modern Pathology 21(129A). e-Pub 2008.
98. Peng L, Liang J, Rashid A, Evans DB, Gomez H, Corley LJ, Abbuzzese JL, Hamilton S, Wang H. High level of nucleolin expression is associated with better prognosis in patients with stage II pancreatic ductal adenocarcinomas. Modern Pathology 21(132A). e-Pub 2008.
99. Taggart MW, Wang H, Maru DM, Tan D, Rashid A. Appendiceal mixed carcinoid-adenocarcinomas share better prognosis associated with goblet cell carcinoid tumors. Modern Pathology 21(137A). e-Pub 2008.
100. Peng L, Rashid A, Evans DB, Vardhacharry GR, Lee JE, Fleming JB, Pisters PWT, Abbuzzese JL, Wolff RA, Wang H. Superior mesenteric vein/portal vein invasion is associated with poor survival in patients with stage II pancreatic ductal carcinomas who received pre-operative chemoradiation. Modern Pathology 21(319A). e-Pub 2008.
101. Wong SJ, Winter K, Meropol NJ, Anne R, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Willett CG. RTOG 0247: a randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer. Journal of Clinical Oncology 26(4021). e-Pub 2008.
102. Kim YW, Upadhyay G, Yao ZX, Kreisman P, Amin R, Jogunoori W, Ahmad M, Shad A, Rashid A, Blake T, Li WP, Sidawy AA, Evans S, Zasloff M, Mishra BH, Reddy PE, Weksberg R, Mishra L. Causal relationship amongst loss of β-2 spectrin, its TGF-β/smad3 adapter function and human Beckwith-Wiedemann syndrome. Hepatology 48(425A). e-Pub 2008.
103. Prishvaian MJ, Blake TM, Kitisin K, Kim SS, Kang A, Rashid A, Tang Y, Mishra B, Reddy EP, Mishra L. Haploinsufficency of CDK4 prevents hepatocarcinogenesis in mice deficient in ELF, a mediator of TGF-beta signalizing. Journal of Clinical Oncology 25(18). e-Pub 2007.
104. Lenzi R, Rashid A, Ordonez N, Raber NM, Varadhachary GR, Floore A, Stork-Shoots L, Warmos M, Erlander M, Abbruzzese JL. Gene profiling validation for cancer classification using known primary carcinoma samples. Journal of Clinical Oncology 25(18). e-Pub 2007.
105. Liang J, Rashid A, Wu TT, Corea AM, Maru D, Corley LJ, Hofstetter WL, Swisher SG, Ajani JA, Hamilton SR, Wang H. High level of nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (hTERT) is associated with better prognosis in patients with esophageal and esophagogastric junction adenocarcinomas 46. e-Pub 2007.
106. Yun C, Prishvaian MJ, Tang Y, Kitisin K, Volpe E, Deng C, Mueller S, Ressom H, Rashid A, Sidawy N, Evans S, Shetty K, Zassloff M, Mishra B, Mishra L. Modulation of stemness in dysfunctional progenitor/stem cells alter cancer formation in the liver. Hepatology 46(4). e-Pub 2007.
107. Kitisin K, Volpe EA, Mendelson J, Jogunoori W, Li C, Deng C, Mueller S, Ressom H, Rashid A, Sidawy A, Evans SRT, Shetty K, Zasloff M, Mishra B, Reddy EP, Johnson L, Mishra L. Evidence that human hepatocellular cancer can arise from hepatic stem cells as a consequence of aberrant TGF-β and IL-6 signaling 46. e-Pub 2007.
108. Varadhachary GR, Talantov D, Jatkoe T, Rashid A, Lenzi R, Chadha R, Baden J, Wang Y, Abbruzzese JL, Raber NM. Prospective study of a 10-gene molecular assay to predict tissue of origin in patients with carcinoma of unknown primary. Journal of Clinical Oncology 25(18). e-Pub 2007.
109. Taggart MW, Chirieac LR, Hamilton SR, Rashid A. Nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (h-TERT) is associated with better survival in patients with stage III colon cancer. Modern Pathology. e-Pub 2007.
110. Mares J, Eisner MP, Dagohoy C, Phan A, Rashid A, Evans DB, Yao JC. Population based study of islet cell carcinoma. Journal of Clinical Oncology 25(18). e-Pub 2007.
111. Liang JJ, Wang H, Rashid A, Wu TT, Cleary KR, Hamilton SR, Evans DB, Hwang RF, Gomez HF, Tan TH, Zhou GS, Abbruzzesse JL, Wang H. Expression of MAPK4 is associated with worse prognosis in patients with pancreatic adenocarcinoma. Modern Pathology. e-Pub 2007.
112. Yao JC, Phan A, Chang DZ, Wolff RA, Jacobs C, Mares JE, Gupta S, Meric-Bernstam F, Rashid A. Phase II study of RAD001 (everolimus) and depot octretide (sandostatin LAR) in advanced low grade neuroendocrine carcinoma. Journal of Clinical Oncology 25(18). e-Pub 2007.
113. Sanchez A, Wu TT, Rashid A, Prieto V, Hamilton SR, Wang H. Esophageal melanoma: a comparison of primary and metastatic lesions. Modern Pathology. e-Pub 2006.
114. Phan AT, Chang D, Rashid A, Meric-Bernstam F, Yao JC. RAD001 and depot octreotide in advanced low-grade carcinoid and pancreatic neuroendocrine tumors. Annals of Oncology 17(30). e-Pub 2006.
115. Phan AT, Wang L, Xie K, Zhang J, Rashid A, Evans D, Vauthey J, Abdalla E, Abbruzzesse JL, Yao JC. Association of VEGF expression with poor prognosis among patients with low-grade neuroendocrine carcinoma. Journal of Clinical Oncology. e-Pub 2006.
116. Yao JC, Phan AT, Chang DZ, Jacobs C, Mares JE, Rashid A, Meric-Bernstam F. Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low-grade neuroendocrine carcinoma. Journal of Clinical Oncology. e-Pub 2006.
117. Beach RA, T-T W, Chan A, White JA, Morris JS, Issa J, Hamilton SR, Rashid A. BRAF mutations in hyperplastic polyposis. Modern Pathology 18:98A, 2005. e-Pub 2005.
118. Liu E, Rashid A, Gao YT, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Fraumeni Jr JF, Hsing AW. Aspirin use and risk of biliary tract cancers. Biliary Tract Cancer International Workshop:42, 2004. e-Pub 2004.
119. Einspahr JG, Alberts DS, Bhattacharrya AK, Martinez ME, Wilkinson J, J-P I, Buckmeier JA, Rashid A, Houlihan S, Lance MP, Hamilton SR. Ki-ras mutations and p53 overexpression in adenomas from a phase III trial of recurrence 43:1128. e-Pub 2004.
120. H-R C, Sturgis EM, Rashid A, DeMonte F, Luna MA, Batsakis JG, El-Naggar AK. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and non-enteric phenotypes. Modern Pathology 17:222A, 2004. e-Pub 2004.
121. Deavers MT, Malpica A, Silva EG, Rashid A. Frequent chromosome 18q loss in ovarian mucinous, and appendiceal mucinous and non-mucinous adenocarcinomas. Modern Pathology 17:196A, 2004. e-Pub 2004.
122. Wang GG, T-T W, Hamilton SR, Rashid A. Frequent loss of chromosome 16q and 18q in ileal carcinoid tumors compared to non-ileal carcinoid tumors and pancreatic endocrine tumors. Modern Pathology 17:132A, 2004. e-Pub 2004.
123. Chan AO, Peng JZ, Lam SK, W-M H, W-M W, Yuen MF, Kwong YL, Rashid A, Wong BYW. Reversal of E-cadherin promote hypermethylation status after Helicobacter pylori eradication. Gastroenterology 43:1128, 2004. e-Pub 2004.
124. T-T W, Chirieac LR, Swisher SG, Komaki RU, Correa AM, Roth J, Rashid A, Hamailton SR, Ajani JA. Post-chemoradiation surgical pathological stage accurately predicts outcome of patients with esophageal or gastroesophageal junction carcinoma. Annual Meeting of the American Society of Clinical Oncology, 2004. e-Pub 2004.
125. Carr K, Yao JC, Rashid A, S-C Y, Szklaruk J, Baker J, J-N V, Curley S, Ellis L, Ajani JA. A phase II trial of imatinib in patients with advanced carcinoid tumor. Annual Meeting of the American Society of Clinical Oncology, 2004. e-Pub 2004.
126. Hsing AW, Rashid A, Han TQ, Wang BS, Shen MC, Deng J, Sakoda L, Niwa S, Gail M, Fraumeni Jr JF, Gao YT. Gallstones and biliary tract cancer. Biliary Tract Cancer International Workshop:34, 2004. e-Pub 2004.
127. Althuis M, Lifang H, Gao YT, Rashid A, Deng J, Wang BS, Shen MC, Sakoda L, Brinton LA, Fraumeni Jr JF, Hsing AW. Reproductive factors and biliary tract cancer risk among woman. Biliary Tract Cancer International Workshop:35, 2004. e-Pub 2004.
128. Sakoda L, Gao YT, Rashid A, Deng J, Shen MC, Han TQ, Wang BS, Zhang BH, Althuis M, Fraumeni Jr JF, Hsing AW. Obesity and risk of biliary tract cancer. Biliary Tract Cancer International Workshop:36, 2004. e-Pub 2004.
129. Leitzmann MF, Gao YT, Rashid A, Wang BS, Deng J, Shen MC, Fraumeni Jr JF, Hsing AW. Physical activity in relation to risk of biliary tract cancer: a population-based study in China. Biliary Tract Cancer International Workshop:37, 2004. e-Pub 2004.
130. Zhang XH, Gao YT, Rashid A, Deng J, Liu E, Wu K, Sun L, Cheng JR, Gridley G, Hsing AW. Tea consumption and risk of biliary tract cancers. Biliary Tract Cancer International Workshop:38, 2004. e-Pub 2004.
131. Rastogi T, Gao YT, Rashid A, Deng J, Fraumeni Jr JF, Hsing AW. Diet and risk of biliary tract cancers. Biliary Tract Cancer International Workshop:39, 2004. e-Pub 2004.
132. Liu E, Rashid A, Gao YT, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Fraumeni Jr JF, Hsing AW. Medical history and risk of biliary tract cancers. Biliary Tract Cancer International Workshop:40, 2004. e-Pub 2004.
133. Hsing AW, Zhang M, O’Brien TR, Rashid A, McGlynn K, Wang BS, Shen MC, Zhang BH, Han TQ, Deng J, Fraumeni Jr JF, Gao YT. Serologic markers of hepatitis B and C infection in relation to biliary tract cancer. Biliary Tract Cancer International Workshop:41, 2004. e-Pub 2004.
134. Hou L, Xu J, Rashid A, Gao YT, Zhang L, Shen MC, Wang BS, Deng J, Sakoda L, Althuis M, Han TQ, Zhang BH, Meyers D, Fraumeni Jr JF, Hsing AW. CYP17 genetic polymorphisms and the risk of biliary tract cancers. Biliary Tract Cancer International Workshop:43, 2004. e-Pub 2004.
135. Andreotti G, Gao YT, Rashid A, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Welch R, Sakoda L, Chanock S, Fraumeni Jr JF, Hsing AW. Polymorphisms of genes in the lipid metabolism pathway and the risk of biliary tract cancers. Biliary Tract Cancer International Workshop:44, 2004. e-Pub 2004.
136. Olsen J, Gao YT, Rashid A, Deng J, Sakoda L, Zhang M, Shen MC, Wang BS, Han TQ, Yeager M, Welch R, Chanock S, Fraumeni Jr JF, Hsing AW. Polymorphisms of estrogen receptors biliary tract cancers. Biliary Tract Cancer International Workshop:45, 2004. e-Pub 2004.
137. Zhang M, Huang WY, Gao YT, Rashid A, Deng J, Sakoda L, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Welch R, Chanock S, Fraumeni Jr JF, Hsing AW. Genetic variants in the DNA repair pathway and risk of gallstones and biliary tract cancers. Biliary Tract Cancer International Workshop:46, 2004. e-Pub 2004.
138. International Workshop BTC. Polymorphisms of genes related to insulin sensitivity and obesity in relation to biliary tract cancer risk. Chang SC, Gao YT, Rashid A, Sakoda L, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Leitzmann MF, Yeager M, Welch R, Chanock S, Fraumeni Jr. JF, Hsing AW(47):47, 2004. e-Pub 2004.
139. McGreogor DK, T-T W, Rashid A, Hamilton SR. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Modern Pathology 17:124A, 2004. e-Pub 2004.
140. Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Roth J, Rashid A, Hamilton SR, T-T W. Residual tumor status predicts long-term survival in esophageal cancer following preoperative chemoradiation and surgery. Modern Pathology 17:112A, 2004. e-Pub 2004.
141. Marcal L, Choi H, Jackson EF, Benjamin RS, Rashid A, Macapinlac H. Use of quantitative dynamic contrast MR imaging to monitor musculoskeletal sarcomas: correlation with FDG-PET and pathology. International Society for Magnetic Resonance in Medicine, Kyoto, Japan, 2004. e-Pub 2004.
142. Zhang M, O’Brien TR, Rashid A, Y-T G, McGlynn K, B-S W, Bai Y, M-C S, B-H Z, Deng J, Fraumeni Jr JF, Hsing AW. Serological markers of hepatitis B and C infection in relation to biliary tract cancer: a population-based study. Hong Kong – Shanghai International Liver Congress, 2004. e-Pub 2004.
143. Leitzmann MF, Gao YT, Rashid A, Wang BS, Deng J, Shen MC, Fraumeni Jr JF, Hsing AW. Physical activity in relation to risk of biliary tract cancer: a population-based study in China. American Journal of Epidemiology 159:S11, 2004. e-Pub 2004.
144. Hou Z, Elasmar SA, Lozano R, Hoff P, Wolff RA, Abbruzzese JL, Ajani JA, Carr K, Rashid A, Yao JC. A pilot study of irinotecan plus cisplatin in patients with metastatic high-grade neuroendocrine carcinoma. Proceedings of American Society of Clinical Oncology 22:375, 2004. e-Pub 2004.
145. Einspahr JG, Alberts DS, Bhattacharrya AK, Martinez ME, Wilkinson J, J-P I, Buckmeier JA, Rashid A, Houlihan S, Lance MP, Hamilton SR. Ki-ras mutations and p53 overexpression in adenomas from a phase III trial of recurrence. Proceedings: 95th Annual Meeting of the American Association for Cancer Research 43:1128, 2004. e-Pub 2004.
146. Rastogi T, Y-T G, Gridley G, Rashid A, Deng J, Fraumeni Jr JF, Hsing AW. Diet and risk of biliary tract cancers: a population-based study in Shanghai, China. Proceedings: 95th Annual Meeting of the American Association for Cancer Research 43:1128, 2004. e-Pub 2004.
147. Hou Z, Elasmer SA, Lozano R, Hoff P, Wolff RA, Abbruzzese L, Ajani JA, Carr K, A <, Yao JC. A pilot study of irinotecan plus cisplatin in patients with metastatic high-grade neuroendocrine carcinoma. Annual Meeting of the American Society of Clinical Oncology, 2003. e-Pub 2003.
148. Yang Q, Cleary KR, Houlihan PS, Yao JC, Swisher SG, Komachi R, Ajani JA, Rashid A, Hamilton SR, T-T W. Prevalence and clinical significance of neuroendocrine differentiation in esophageal and gastroesophageal junction adenocarcinomas. Modern Pathology 16:137A, 2003. e-Pub 2003.
149. Shen SS, Rashid A, Tunstead JR, S-H L. CEACAM1, a CEA related adhesion molecule, is down-regulated in hepatocellular carcinoma. Modern Pathology 16:285A, 2003. e-Pub 2003.
150. Thomas MB, Faria S, Tamm E, Rashid A, Charnsangavej C, Dancy J, Abbruzzese J. A phase II study of OSI-774 in unrestable hepatocellular carcinoma. Clinical Cancer research 9:6092S, 2003. e-Pub 2003.
151. Pawlik TM, Smith DL, Pisters PW, Rashid A, Lee JE, Curley SA, Morris JS, Ayers JD, Kaw M, Lahoti S, Evans DB, J-N V. Contemporary assessment of extrahepatic bile duct strictures. Gastroenterology 174:M1992, 2003. e-Pub 2003.
152. Sakoda L, Y-T G, Rashid A, Deng J, Shen MC, Han TQ, Wang BS, Althuis M, Fraumeni JF, Hsing AW. Obesity and risk of biliary tract cancers. American Journal of Epidemiology 157:251S, 2003. e-Pub 2003.
153. Althuis M, Y-T G, Rashid A, Deng J, Wang BS, Shen MC, Sakoda L, Brinton LA, Fraumeni JF, Hsing AW. Hormonal factors and biliary tract cancers risk among women. American Journal of Epidemiology 157:34S, 2003. e-Pub 2003.
154. Kim SG, T-T W, Lee JH, Yun YK, J-P I, Hamilton SR, Rashid A. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasms and serous microcystic adenoma of pancreas. American College of Surgeons, 89th Annual Clinical Congress, 2003. e-Pub 2003.
155. Yao JC, Yeung SJ, Rashid A, Szklaruk J, Baker J, Carr N, Vauthey N, Ellis L, Curley S, Ajani J. Early results of a phase II trial of imatinib in patients with advanced carcinoid tumors. Annual Meeting of the American Society of Clinical Oncology, 2003. e-Pub 2003.
156. Smith DL, J-C S, Rashid A, Morat L, Yang Q, Vauthey, J-N. Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for metastatic colon cancer. Annals of Surgical Oncology 10:74S, 2003. e-Pub 2003.
157. J-H L, S-J P, J-S S, J-H N, Choi C, S-W J, Rashid A, Hamilton SR, T-T W. Aberrant promoter methylation profile in premalignant lesions and T1 adenocarcinoma of the stomach. Modern Pathology 16:126A, 2003. e-Pub 2003.
158. Maru DM, Canada A, Rashid A, T-T W, Cleary KC, Hamilton SR. Frequent 18q loss in appendiceal mucinous and non-mucinous adenocarcinoma. Modern Pathology 16:127A, 2003. e-Pub 2003.
159. Stancu M, T-T W, Wallace C, Hamilton SR, Rashid A. Goblet cell carcinoid of the appendix: a clinico-pathologic and molecular analysis. Modern Pathology 16:134A, 2003. e-Pub 2003.
160. Bedeir SA, Soliman AS, El-Ghawalby N, Rashid A, Bassiouni N, Bondy M L, Li D, Houlihan P, Levin B, Abbruzzese JL, Hamilton SR. High proportion of G-to-T transversion in codon 12 of the K-ras proto-oncogene in Egyptian pancreatic cancer. 93th Annual Meeting of the American Association for Cancer Research 43:396, 2002. e-Pub 2002.
161. Kim SG, Chan AO, Bedeir SA, J-PJ I, Rashid A. CpG island methylation in biliary, ampullary, and duodenal cancers. 93th Annual Meeting of the American Association for Cancer Research 43:1126, 2002. e-Pub 2002.
162. Wei C, Rashid A, Amos CI, Frazier ML. Coexpression of COX-2 and LKB1 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome. Cancer Epidemiology Biomarkers and Prevention 11:D303, 2002. e-Pub 2002.
163. Chan AO, Bedeir SA, Kim SG, J-PJ I, Rashid A. CpG island methylation in carcinoid tumor and pancreatic endocrine tumor. 93th Annual Meeting of the American Association for Cancer Research 43:763, 2002. e-Pub 2002.
164. Persad R, Liu C, Houlihan PS, T-T W, Rashid A. Overexpression of caspase-3 in hepatocellular carcinoma 15:291A, 2002. e-Pub 2002.
165. Yao JC, Najam AA, Rashid A, Lynch P, Gagneja H, Agarwal B, Giacco G, Putnam J, Swisher SG, Roth J, Ajani JA. Clinical and pathological features of patients with carcinoma associated with Barrett’s metaplasia: an analysis of 1,162 patients with esophageal or esophagogastric junction cancer. Annual Meeting of the American Society of Clinical Oncology, 2002. e-Pub 2002.
166. Soliman AS, Chan AO, Rashid A, Mokhtar N, Almarsi N, Ozbek U, Yaghan R, Kandilci A, Dizdaroglu F, Bedeir AS, Bondy ML, Issa JP, Levin B, Hamilton SR. Differing DNA methylation patterns of colorectal cancers in Middle Eastern countries. International Journal of Cancer Supplement 13:173, 2002. e-Pub 2002.
167. J-H L, Abraham SC, J-H N, Choi C, M-C L, C-S P, S-W J, Rashid A, Hamilton SR, T-T W. Microsatellite instability in gastric precancerous lesions and adenocarcinomas. Modern Pathology 15:136A, 2002. e-Pub 2002.
168. J-H L, Abraham SC, J-H N, Choi C, M-C L, C-S P, S-W J, Rashid A, Hamilton SR, T-T W. APC gene mutations in gastric adenomas and flat dysplasias protect against progression. Modern Pathology 15:135A, 2002. e-Pub 2002.
169. Lynch P, Kohlmann W, Ward P, Rashid A, Broaddus R, Cleary K, Hamilton S. Clinical implantation of microsatellite instability (MSI) testing and mismatch repair-gene-associated protein immunohistochemistry (IHC) for hereditary nonpolyposis colorectal cancer (HNPCC) screening at a comprehensive cancer center. World Congress of Gastroenterology, 2002. e-Pub 2002.
170. Shen L, Houlihan PS, Robinson R, Rashid A, Hamilton SR, J-PJ I. Mapping CpG island methylation in normal mucosa of patients with colon cancer. Proceedings: 93th Annual Meeting of the American Association for Cancer Research 43:1128, 2002. e-Pub 2002.
171. Wu TT, Rashid A, Lee LA, Bhagavan MD, Abraham, SC. Upper gastrointestinal tract injury in patients receiving Kayexalate in sorbitol: histological, clinical, and endoscopic findings. Modern Pathology 14:98A, 2001. e-Pub 2001.
172. Chan AO, Broaddus RB, J-PJ I, Hamilton SR, Rashid A. CpG island methylation and chromosome 1p loss in aberrant crypt foci. Gastroenterology and Hepatology 16(1):29, 2001. e-Pub 2001.
173. Chan AO, J-PJ I, Morris JS, Hamilton SR, Rashid A. CpG island methylation and the pathogenesis of hyperplastic polyposis. Gastroenterology 120:A292, 2001. e-Pub 2001.
174. Liu C, Rashid A, Ruchelli E, Seeger C. Beta catenin gene expression in hepatocellular carcinoma and hepatoblastoma. Modern Pathology 14:199A, 2001. e-Pub 2001.
175. Kabbani W, Houlihan PS, Luthra R, Hamilton SR, Rashid A. Genetic alterations in appendiceal adenocarcinomas: Frequent K-ras mutations and lack of microsatellite instability. Modern Pathology 14:87A, 2001. e-Pub 2001.
176. Mishra L, Tran CD, Bhanumathy CD, Tang Y, Rashid A, Danovitch S, Fluery T, Mishra B, Deng C. TGF beta signaling by SMAD2/3 and ELF spectrins results in bile duct formation and is disrupted in primary biliary cirrhosis. Gastroenterology 118:A2, 2000. e-Pub 2000.
177. Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, Lee FY, Diehl AM. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29(4):1131-8, 1999. e-Pub 1999. PMID: 10094957.
178. Monga SPS, Tang Y, Rashid A, Mishra B, Diehl AM, Mishra L. Ontogeny, function and role in liver regeneration of ITIH-4, a liver specific serine protease inhibitor. Gastroenterology 116:A1247, 1999. e-Pub 1999.
179. Monga SPS, Danovitch S, Rashid A, Mishra B, Fleury T, Mishra L. Correlation of inhibition studies of ELF-3, a  spectrin with primary biliary cirrhosis. Gastroenterology 116:A1248, 1999. e-Pub 1999.
180. Mishra L, Tang Y, Monga SPS, Weinstein M, Yang X, Rashid A, Diehl AM, C-X D. Ontogeny and role in liver regeneration of SMAD2 and SMAD3: essential components in liver formation. Gastroenterology 116:A1248, 1999. e-Pub 1999.
181. Rashid A, Koteish AK, Cortez-Pinto H, X-T W, Yang SQ, Coyle W, Diehl AM. Subcellular localization of uncoupling protein (UCP)2 and evidence for increased UCP2 expression in nonalcoholic steatohepatitis. Hepatology 30:405A, 1999. e-Pub 1999.
182. Monga PS, Weinstein M, Rashid A, Tang Y, Iqbal S, Deng C, Mishra L. Essential cooperative function of TGF beta signalizing molecules SMAD2/3 for liver formation can be rescued by HGF. Hepatology 30:318A, 1999. e-Pub 1999.
183. Mishra L, Monga SPS, Rashid A, Danovitch S, Fluery T, Iqbal SA, Tang Y, Deng C, Mishra B. Disruption of TGF beta signaling by SMAD2, SMAD3 and ELF spectrins in primary biliary cirrhosis. Hepatology 30:401A, 1999. e-Pub 1999.
184. Monga SPS, Rashid A, Wildner O, Condotti F, Mishra B, Blaese RM, Mishra L. Hepatic stem cells in mouse embryonic liver explant cultures. Development Biology 210:200, 1999. e-Pub 1999.
185. Mishra L, Monga SP, Danovitch S, Rashid A, Fluery T, Mishra B. ELF-3 a novel spectrin is required for the development of intrahepatic bile ducts. Development Biology 210:199, 1999. e-Pub 1999.
186. Iqbal S, Monga SP, Tang Y, Rashid A, Mishra B, Diehl AM, Mishra L. Ontogeny, function and role in liver regeneration of ITIH-4, a liver specific serine protease inhibitor. Development Biology 210:86, 1999. e-Pub 1999.
187. Jackson PE, Rashid A, G-S Q, Laken SJ, Friesen MF, Vogelstein B, Groopman JD. Specific p53 mutations detected in hepatocellular carcinomas by electrospray mass spectrometry. 90th Annual Meeting of the American Association for Cancer Research 40:619, 1999. e-Pub 1999.
188. Rashid A, Houlihan PS, Giardiello FM, Hamilton SR. Topographic dysregulation of p21Waf-1/Cip1 and proliferation in hyperplastic polyps, but infrequent K-ras mutations and lack of p53 overexpression. Modern Pathology 12:82A, 1999. e-Pub 1999.
189. Y-Y T, H-H Y, Rashid A, Ahuja N, Hamilton SR, Choti MA, Petersen GM. Prognostic significance of chromosome 18q allelic loss in metastatic colorectal cancer. 90th Annual Meeting of the American Association for Cancer Research 40:317, 1999. e-Pub 1999.
190. Ueki T, Rashid A, Choti MA, Hamilton SR. Molecular evaluation of resection margin status in patients with rectal cancer. Gastroenterology 116:A521, 1999. e-Pub 1999.
191. Weinstein M, Monga SPS, Rashid A, Mishra L, C-X D. SMAD2/3 deficiency defines an essential development checkpoint in liver formation. Gastroenterology 116:A566-A567, 1999. e-Pub 1999.
192. Franklin S, Rashid A, Yang SQ, Lin HZ, Diehl AM. Dieting increases hepatic necroinflammation in obese mice with fatty livers. Gastroenterology 116:A1210-A1211, 1999. e-Pub 1999.
193. Monga SPS, Rashid A, Wildner O, Condotti F, Mishra B, Blaese RM, Mishra L. Growth and culture of hepatic stem cells utilizing liver explant cultures. Gastroenterology 116:A1247, 1999. e-Pub 1999.
194. Mishra L, Monga SPS, Weinstein M, Rashid A, Laxman R, C-X D. Effects of ethanol and lipopolysaccharide on livers of Fgfr4 and Fgfr3/4 knockout mice. Gastroenterology 116:A1247, 1999. e-Pub 1999.
195. Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 22(3):293-8, 1998. e-Pub 1998. PMID: 9500770.
196. Revelon G, Rashid A, Bluemke D. Sclerosing cholangitis: MR imaging findings with pathological correlation. International Society for Magnetic Resonance in Medicine, 1998. e-Pub 1998.
197. Ahrendt SA, Rashid A, Chow JT, Pitt HA, Eisenberger KF, Sidransky D. Effect of p53 overexpression and K-ras gene mutations on survival in patients with primary sclerosing cholangitis-associated cholangiocarcinoma. Gastroenterology 114(A555), 1998. e-Pub 1998.
198. Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, Pitt HA, Sidransky D. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. Annual meeting of the Association for Academic Surgery, 1998. e-Pub 1998.
199. Monga SPS, Rashid A, Wildner O, Condotti F, Mishra L. Ex vivo embryonic liver explant cultures: a model for studying liver development. Hepatology 28:603A, 1998. e-Pub 1998.
200. Tchou J, Lin X, Hirohashi S, Rashid A, Nelson WG. CpG island methylation near the GSTP1 promoter in hepatocellular carcinoma: the role of GSTP1 expression in human. Hepatology 28:174A, 1998. e-Pub 1998.
201. Monga SPS, Lee J, Lin HZ, Diehl AM, Rashid A, Mishra L. PRAJA1 and ELF cell polarity proteins from developing liver expressed at different and distinct time points during liver regeneration. Hepatology 28:178A, 1998. e-Pub 1998.
202. Alexander J, Watanabe T, Li SC, Wu TT, Rashid A, Hamilton SR. Histopathological screening of sporadic colon cancers for tumors with DNA replication errors (RER). Modern Pathology 11:60A, 1998. e-Pub 1998.
203. Rashid A, J-S W, B-X L, G-S Q, Hamilton SR. Genetic alterations in hepatocellular carcinomas from the People’s Republic of China (P.R.C.). Proceedings: 89th Annual Meeting of the American Association for Cancer Research 39:547, 1998. e-Pub 1998.
204. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 10:63A, 1997. e-Pub 1997. PMID: 9207270.
205. Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 10:67A, 1997. e-Pub 1997. PMID: 9500770.
206. Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Epithelial dysplasia and dysplasia and dysregulation of Proliferation in fundic gland polys from patients with familial adenomatous polyposis. Modern Pathology, 1997. e-Pub 1997.
207. Wu TT, Rezai B, Rashid A, Moskaluk C, Yardley JH, Hamilton SR. Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome. Modern Pathology 9:68A, 1996. e-Pub 1996.
208. Rashid A, Hamilton SR. Genetic epidemiology of altered c-K-ras protooncogene and p53 suppressor gene in colorectal adenomas. Modern Pathology 9:64A, 1996. e-Pub 1996.
209. Pasricha PJ, Bedi A, Rashid A, Hamilton SR, Akhtar AJ, O'Connor K, Giardello FM. Inhibition of apoptosis in familial adenomatous polyposis (FAP) and its modification by Sulindac. Gastroenterology 108:A523, 1995. e-Pub 1995.
210. Rashid A, Milgraum LZ, Pasternack G, Kuhajda F, Hamilton SR. Expression of fatty acid synthetase in colorectal cancer. Modern Pathology 8:67A, 1994. e-Pub 1994.
211. Sharon J, Rashid A, C-YY K. Generation of chimeric, fragmented, and high affinity antibodies by genetic engineering. Immunobiology 4, 1989. e-Pub 1989.
212. Phan AT, Rashid A, Luthra R, Lopez-Alvarez E, Swisher R, Komachi R, Bresalier R, Ajani JA. Molecular predictors of patients with localized upper gastrointestinal cancers after chemoradiation.
213. Munoz NM, Dupuis CJ, Dixon KP, Williams KL, Maldonado KL, Rashid A, Tam AL. Generation and characterization of colorectal cancer cell lines from the Buffalo rat. Proceedings: AACR Annual Meeting.
214. Liang J, Rashid A, Wu TT, Corea AM, Maru D, Corley LJ, Hofstetter WL, Swisher SG, Ajani JA, Hamilton SR, Wang H. High level of nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (hTERT) is associated with better prognosis in patients with esophageal and esophagogastric junction adenocarcinomas. Proceedings: 98th Annual Meeting of the American Association for Cancer Research.
215. Kitisin K, Volpe EA, Mendelson J, Jogunoori W, Li C, Deng C, Mueller S, Ressom H, Rashid A, Sidawy A, Evans SRT, Shetty K, Zasloff M, Mishra B, Reddy EP, Johnson L, Mishra L. Evidence that human hepatocellular cancer can arise from hepatic stem cells as a consequence of aberrant TGF-β and IL-6 signaling. Proceedings: 98th Annual Meeting of the American Association for Cancer Research.
216. Gaur P, Samuel S, Bose D, Dallas NA, van Buren II G, Gray MJ, Xia L, Fan A, Rashid A, Yao JC, Ellis LM. Blockage of in vivo tumor growth of newly established human midgut carcinoid tumors by Src inhibition. American Society of Clinical Oncology Gastrointestinal Cancer Symposium.
217. Al-Assi K, Hatia R, Rallapalli V, Abugabal YI, Abdelhakeem A, Abdel-Wahab, R, Raghav KPS, Jalal PK, Kaseb A, Rashid A, Li D, Hassan MM. Gallbladder disease and the risk of hepatocellular carcinoma. Proceedings: AACR Annual Meeting.
218. Shetty K, C-X D, Jogunoori WS, Amdur R, Resar LS, Latham PS, Mazumder R, Horvath A, B-N N, Li S, Wu X, Yu H, Wong LL, White J, Silver S, Rashid A, Kundra V, Wang XW, Mishra L. Pathway specific functional biomarkers for the early detection of liver cancer. Proceedings: AACR Annual Meeting.
219. Rajendran P, Ulusan A, W-M D, Kapoor S, Mohammed A, Sei S, Rashid A, Brown PH, Vilar E, Dashwood R. Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention. Proceedings: AACR Annual Meeting.

Book Chapters

1. Rashid A. Small bowel and colon: genetics of sporadic cancers. In: Molecular Pathology of Neoplastic Diseases of the Gastrointestinal Tract. Springer Publishing Company, 2012.
2. Chan AOO, Rashid A. Epigenetics in gastric cancer. In: Reviews in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 2010.
3. Chan AOO, Rashid A. Diagnosis: history, clinical and histopathology. In: Intestinal Gastric Cancer. Blackwell Publishing Ltd, 2009.
4. Hsing AW, Rashid A. Biliary tract cancer. In: Cancer Epidemiology and Prevention. Oxford University Press, 787-800, 2006.
5. Rashid A. Recent advances in histopathology of gastrointestinal cancers: prognostic and therapeutic assessment of colorectal cancers. In: Gastrointestinal Cancers, MD Anderson Cancer Care Series. Springer Sciences, 14-27, 2004.
6. Wu TT, Rashid A. Recent advances in molecular classification and prognosis of colorectal cancers. In: Cancer Diagnostics: Current and Future Trends. Humana Press, Inc, 429-452, 2004.
7. Rashid A, Ahrendt SA. Cancer of the bile ducts and gallbladder: pathology and natural history of cholangiocarcinoma and gallbladder carcinoma. In: Gastrointestinal Oncology. Oxford University Press, 420-427, 2004.
8. Ho L, Rashid A. Predictors of response to treatment for adenocarcinoma of the stomach. In: Atlas of Cancer. Lippincott Williams & Wilkins, 2002.

Letters to the Editor

1. Ettinger DS, Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handorf C, Harris EI, Jacobs CD, Javale M Khushalani NI, Kvols L, Lenzi R, Lewis NL, Rashid A, Saltz L Shulman LN, Zager JS, Zhen W. Occult primary. Journal of National Comprehensive Oncology 6: 1026-1060, 2008.
2. Anderlini P, Swanston N, Rashid A, Bueso-Ramos C, Macapinlac H, Champlin RE. Evidence of a graft-versus-host Hodgkin's Lymphoma effect in the setting of extensive bone marrow involvement 14: 478-480, 2008.
3. Chan AO, Chu KM, Huang C, Lam KF, Leung SY, Sun YW, Ko S, Xia HH, Cho CH, Hui WM, Lam SK, Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 56: 595-7, 2007.
4. Chan AOO, S-K L, Wong BC, Y-L K, Rashid A. Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related?. The American Journal of Pathology 163: 370-371, 2003.